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CHAPTER ONE:
INTRODUCTION

Swallowing and cough are two vital functions that are reflexive in nature and are related to
each other in terms of shared neural and anatomical space. When a disorder impacts normal and
effective swallowing and/or cough, the consequences can be life-threatening. Evaluation and
treatment of swallowing and cough disorders can fall under the scope of practice of the speechlanguage pathologist and speech-language pathologists often are leading professionals.
Furthermore, much of the current research on swallowing and cough is spearheaded by speechlanguage pathologists often working with a multi-disciplinary team. The focus of this dissertation
is on the clinical evaluation of cough and swallowing, practice patterns of voluntary cough
assessment during the evaluation of swallowing, and novel methods of evaluating acoustic
voluntary cough waveforms in patients with and without swallowing impairment. The results will
provide important information regarding the state of cough assessment tools for clinical
swallowing evaluation, clinical practice patterns of voluntary cough assessment, and differences
in acoustic cough signals between safe and unsafe swallowers in individuals with Amyotrophic
Lateral Sclerosis (ALS).
It is important to understand the basic terminology, physiology, and neurophysiology of
swallow and cough in order to frame and interpret the studies included in this dissertation. This
introduction is designed to provide the background and motivation for the subsequent
investigations. Swallowing is a complex sensory and motor function; it is described by its clinical
1

characteristics such as coughing and choking while eating or drinking. Dysphagia is the term that
denotes disordered swallowing (Logemann, 1984). Unidentified or untreated dysphagia may lead
to a pulmonary infection termed, aspiration pneumonia (Ebihara, 2016). Evaluation of swallowing
function is performed on a continuum. Swallowing screening implies a pass/fail criteria, clinical
swallowing evaluation (CSE) is a more in depth evaluation of swallowing, and finally, the
modified barium swallow (MBS) study is considered the gold standard instrumental assessment
of swallowing ability. The Penetration Aspiration Scale (PAS) often is used during gold standard
swallowing assessment to rate swallowing function and denote level of airway compromise and
the patient’s ability to successfully eject material from the airway (Rosenbek, Robbins, Roecker,
Coyle, & Wood, 1996).
Cough and swallowing are intricately related. Physiologically, cough consists of “an
inspiratory effort (inspiratory phase), followed by a forced expiratory effort against a closed glottis
(compressive phase) followed by opening of the glottis and rapid expiratory airflow (expulsive
phase)” (Widdicombe & Fontana 2006, p. 10). Clinically, the cough is a respiratory event that
serves to maintain ventilation by protecting the lower airways (West 1995). Cough, a vital airway
protective mechanism, is particularly important for those with disordered swallowing. Dystussia,
or disordered cough is a key clinical feature of dysphagia and described by its clinical features.
Physiologically, dystussia reduces a patient’s ability to protect his/her airway. And clinically,
dystussia decreases an individual’s ability to protect their airway and thus greatly increases the
risk for aspiration, subsequent aspiration pneumonia, and excess hospitalizations (Ebihara, 2016;
Hegland, Okun, & Troche, 2014; Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008; Plowman,
Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016; Smith Hammond, 2001).
Although the MBS provides good visualization of a patient’s ability to protect the airway
2

and direct visualization of cough effectiveness, it is not always performed. The CSE is often
implemented in place of, or prior to an MBS and is a critical component of the swallowing
evaluation but fails to identify all those with unsafe swallowing especially those who do not
respond to deep penetration or aspiration with a cough. Therefore, clinicians rely on clinical signs
and symptoms to detect dysphagia or dystussia.
Respiratory, cough, and swallowing impairments are highly prevalent in individuals with
neuromuscular diseases such as Amyotrophic Lateral Sclerosis (ALS) and Parkinson’s disease
(PD).1Dystussia has been described in neurodegenerative disease populations such as PD, Stroke,
and ALS (Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008; Plowman, Watts, Robison, Tabor,
Dion, Gaziano, Vu, & Gooch, 2016; Smith Hammond, 2001) by using gold standard physiologic
analysis of airflow waveforms called cough spirometry. Although it appears that voluntary cough
production is related to airway protection status during swallowing in several patient populations,
the gold standard methodology to test cough objectively is costly, the analysis labor intensive and
time consuming, and requires extensive training to perform expert evaluation of physiologic cough
waveforms. Given the limitations for the application of gold standard cough assessment, clinicians
may not have the necessary tools to correctly detect impaired cough. Cough evaluation may
therefore be under-utilized while evaluating dysphagia symptoms. While current clinical

1

(Ali, Wallace, Schwartz, Decarle, Zagami, & Cook, 1996; Benditt & Boitano, 2013;
Bogaard, Hovestadt, Meerwaldt, Vd Meche, & Stigt, 1989; Brown, 1994; Bushmann, Dobmeyer,
Leeker, & Perlmutter, 1989; Coates & Bakheit, 1997; De Bruin, De Bruin, Lees, & Pride, 1993;
Ebihara, Saito, Kanda, Nakajoh, Takahashi, Arai, & Sasaki, 2003; Fontana, Pantaleo, Lavorini,
Benvenuti, & Gangemi, 1998; Gross, Mahlmann, & Grayhack, 2003; Hegland, Okun, & Troche,
2014; Hunter, Crameri, Austin, Woodward, & Hughes, 1997; Miller, Noble, Jones, & Burn, 2006;
Nagaya, Kachi, Yamada, & Igata, 1998; Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008;
Saleem, 2005; Sathyaprabha, Kapavarapu, Pall, Thennarasu, & Raju, 2005; Troche, Okun,
Rosenbek, Musson, Fernandez, Rodriguez, Romrell, Pitts, Wheeler-Hegland, & Sapienza, 2010;
Troche, Brandimore, Godoy, & Hegland, 2014; Troche, Huebner, Rosenbek, Okun, & Sapienza,
2011; Tzelepis, Mccool, Friedman, & Hoppin Jr, 1988).
3

evaluation of cough is focused on cough frequency, cough reflex testing (often using tussive
agents), voluntary cough measures, and patient subjective ratings of severity, little is known
regarding the reliability or validity of clinician perceptions of voluntary cough effectiveness or the
acoustic characteristics of cough during the clinical swallow evaluation. A recent study
investigated the perceptual features of cough (Laciuga, Brandimore, Troche, & Hegland, 2016),
and found that coughs with specific perceptual features also shared airflow characteristics.
However, further work is warranted to determine specific disordered features of impaired cough
that relate to airway protection in multiple patient populations. Currently, there is little information
on the clinical use of perceptual cough ratings and there are no validated screening tools that
support clinician rating of cough impairment or that are designed to determine the relation of such
ratings to airway protection during swallowing. There remains a clinical need for a cost effective,
readily available, low technology, sensitive and specific clinical screening tool of voluntary cough
that may aide in determining an individual’s risk for aspiration during swallowing.
Eupnea/Breathing
All mammals engage in breathing behaviors. In humans, the transition from a breathing
state to swallowing is an essential life sustaining behavior.2 The processes of breathing,
swallowing, and coughing (airway protection) are interrelated at both neurological and
physiological levels (Gestreau, Milano, Bianchi, & Grelot, 1996; Pitts, Rose, Mortensen, Poliacek,

2

(Feroah, Forster, Fuentes, Lang, Beste, Martino, Pan, & Rice, 2002; Gross, Atwood, Ross,
Eichhorn, Olszewski, & Doyle, 2008; Hadjikoutis, Pickersgill, Dawson, & Wiles, 2000; Kelly,
Drinnan, & Leslie, 2007; Pitts, Morris, Segers, Poliacek, Rose, Lindsey, Davenport, Howland, &
Bolser, 2016; Pitts, Rose, Mortensen, Poliacek, Sapienza, Lindsey, Morris, Davenport, & Bolser,
2013b; Preiksaitis & Mills, 1996; Stanford, Galvin, & Rooholamini, 1988; Terzi, Orlikowski,
Aegerter, Lejaille, Ruquet, Zalcman, Fermanian, Raphael, & Lofaso, 2006; Wilson, Thach,
Brouillette, & Abu-Osba, 1981)
4

Sapienza, Lindsey, Morris, Davenport, & Bolser, 2013b; Troche, Brandimore, Godoy, & Hegland,
2014). Quick adaptation from one behavior to another allows for normal airway protection. It is
essential to understand the neuroanatomical function of normal breathing including lung function,
swallowing, and coughing in order to identify a disordered state. Eupnea (i.e. quiet breathing) is a
rhythmic respiratory pattern to move air for ventilation and gas exchange (Bautista, 2014; Bianchi,
Denavit-Saubie, & Champagnat, 1995; Bolton, Chen, Wijdicks, & Zifko, 2004; Bonham, 1995;
Champagnat, 2003; Clark & Von Euler, 1972; Gray, Janczewski, Mellen, Mccrimmon, &
Feldman, 2001; Von Euler, 1986; Wang, 1964; West, 1995) Eupnea can be divided into three
phases: 1) inspiration; 2) post-inspiration (i.e. early expiration); and 3) expiration (Bianchi, 1995;
Richter, 1982; Richter, 1986). The lungs do not have an internal mechanism to produce the
rhythmic pattern that characterizes eupnea. As such, eupnea is centrally mediated.
Breathing is controlled via brainstem pathways. The motor neurons that drive respiratory
muscles are divided into three groups: 1) sub-nucleus of the nucleus tractus solitaries (NTS) and
the dorsal respiratory group (DRG) in caudal dorsomedial medulla; 2) ventral respiratory group in
ventrolateral medulla (VRG); and 3) pontine respiratory group (PRG) in dorsolateral pons (Abdala,
Rybak, Smith, & Paton, 2009; Ellenberger & Feldman, 1988, 1990). The Raphe and retrotrapezoidal nucleus (RTN/PF) (which overlaps with the para-facial respiratory group) also play a
role in the activation of inspiratory and expiratory driven neurons (Connelly, Ellenberger, &
Feldman, 1989). Dorsal inspiratory neurons have monosynaptic connection with contralateral
phrenic motoneurons (Averill, Cameron, & Berger, 1985; Cohen, 1974). The basic breathing
rhythm originates in the ventral reparatory group (Smith, Ellenberger, Ballanyi, Richter, &
Feldman, 1991).
Inspiration is controlled via the brainstem within the ventral and dorsal respiratory groups,
5

which activate premotor neurons, and phrenic motorneurons located within the ventral horn of the
cervical spinal cord segments 3-6 (Berger, 1979; Gordon, 1990; Loewy & Burton, 1978). External
intercostal muscles then contract to elevate the anterior rib cage and that contraction draws down
the diaphragm (Troyer, 1985). Simultaneously, the posterior cricoarytenoid (laryngeal abductor)
activation allows for passage of air through the glottis (the space between the vocal folds)
(Berkowitz, Chalmers, Sun, & Pilowsky, 1999). Laryngeal adductors (thyroarytenoid, lateral
cricoarytenoid, and interarytenoids) slightly narrow the glottis during post inspiration (Poliacek,
Stransky, Jakus, Barani, Tomori, & Halasova, 2003). Neurons whos cell bodies are within the
spinal cord termed ‘motoneurons’ supply a method of activation to muscles; the motoneruons that
move muscles within the larynx can be found in the caudal brainstem near the nucleus
retroambiguus (Berkowitz, Chalmers, Sun, & Pilowsky, 1999; Bieger & Hopkins, 1987).
Expiration during quiet breathing occurs as a result of passive recoil from the lungs and
negative atmospheric pressure (relative to thoracic pressure) (Iscoe, 1998), allowing air to be
expelled (Campbell, 1955). Minimal abdominal motor drive occurs during the expiratory phase of
eupnea (Abdala, Rybak, Smith, & Paton, 2009). Attachment of the lungs to the chest wall via the
pleural space allows for movement of the lungs during breathing (Agostoni, 1986).
Essential gases such as oxygen, carbon dioxide, and hydrogen are monitored in the body
by peripheral chemoreceptors within the carotid and aortic bodies; they then project to the NTS
(Donoghue, 1985). These receptors drive neuron activity within the brainstem and sleep-wake
centers, which then moderate interactions with other airway protective pattern generators (cough,
swallow, etc.) (Guyenet, Mulkey, Stornetta, & Bayliss, 2005; Lindsey, Ott, Nuding, Segers,
O'connor, & Morris, 2011). Their interactions are also termed “reconfiguration.” More
specifically, to describe changes in excitability of eupnea neural network components; these
6

networks are altered based on evaluation of incoming sensory information into the nucleus tractus
solitarius (NTS) (Baekey, Morris, Gestreau, Li, Lindsey, & Shannon, 2001; Lindsey, Hernandez,
Morris, Shannon, & Gerstein, 1992; Pitts, Morris, Segers, Poliacek, Rose, Lindsey, Davenport,
Howland, & Bolser, 2016; Pitts, Rose, Mortensen, Poliacek, Sapienza, Lindsey, Morris,
Davenport, & Bolser, 2013a; Rose, Pitts, Poliacek, Davenport, Morris, & Bolser, 2011; Shannon,
2000).
In vivo translational research studies have elucidated the sensory-neural pathways that
regulate breathing/eupnea. Cranial nerve X, the vagus, arises from the inferior and superior vagal
ganglia (nodose and jugular respectively) and relays (transports) lung sensory information
(Canning, Mazzone, Meeker, Mori, Reynolds, & Undem, 2004; Ootani, Umezaki, Shin, & Murata,
1995). Lung sensory receptors differ in both chemical and mechanical responsiveness, anatomical,
embryological, and physiological attributes. They send information to the brainstem respiratory
network.
Alterations of the Eupneic/Breathing Pattern
It is theorized that the rhythm of breathing may be altered for many reasons such as
sneezing, coughing, exercise, and breath holding. Complicated fine motor behaviors such as
speaking and swallowing also may change the basic rhythm of breathing. Essential human
functions such as swallowing and respiratory defensive actions such as coughing may be
disordered and thus are a specific area of interest to researchers. The primary function of the lungs
is to allow for ventilation or the exchange of oxygen and carbon dioxide. Oxygen is moved into
the blood stream and carbon dioxide is removed. West (1995) describes a series of fundamental
input, processing, and output interactions between pulmonary and cardiac systems to produce
breathing and allow for ventilation. The input system is comprised of higher brain activity (cortex
7

and limbic system) that receives information from mechanoreceptors and chemoreceptors.
Mechanoreceptors are afferent (sensory) receptors that respond to changes in the airway
and lungs. Mechanoreceptor subtypes can be classified based on the rate of adaptation. Adaption
refers to how the sensory system changes in terms of the responsiveness to a stimulus after a
constant stimulus is presented (Canning, Mori, & Mazzone, 2006). These subtypes include: 1)
slowly adapting pulmonary stretch receptors (SARs); 2) rapidly adapting pulmonary irritant
receptors (RARs) (Canning, Farmer, & Mori, 2006; Canning, Mori, & Mazzone, 2006); 3)
bronchopulmonary C-fibers (afferent) that can be intrapulmonary, extra pulmonary, tracheal, or
bronchial (Canning, Farmer, & Mori, 2006); 4) intrapulmonary juxtucapillary or also termed “Jreceptors” which react to pulmonary edema or pneumonia (Canning, Farmer, & Mori, 2006; West,
1995); and 5) baroreceptors that come in through the nucleus tractus solitarius (NTS) and excite
cells in the aorta in response to the stretch of blood vessels (Ott, Nuding, Segers, Lindsey, &
Morris, 2011).
Chemoreceptors sense changes in blood gases including oxygen (O2), carbon dioxide
(CO2), pH concentrations, and can be described anatomically in terms of peripheral (airway) and
central (neural) loci (Heymans, 1927). They have been described as the most important regulators
of breathing (Buchanan, 2013). Peripheral chemoreceptors (aortic and carotid) have many
important roles to regulate gas exchange function and are responsible for 25% of chemoreceptor
drive of ventilation (Lahiri, 1975). Peripheral chemoreceptors stimulate respiration under the
following conditions: 1) during changes in arterial PO2 (decreased oxygen in arteries and tissue)
(Green, 1986); 2) during changes in blood pH (non-respiratory problems such as metabolic
alkalosis and acidosis); and 3) during depression of central chemoreceptors (Dejours, 1962;
Dejours, 1963; Hornbein, 1961). Under the influence from anesthesia or narcotics; peripheral
8

chemoreceptors may become the primary stimulus for ventilation (Takakura, Moreira, Colombari,
West, Stornetta, & Guyenet, 2006). Central chemoreceptors are responsible for 75% of central
drive for ventilation and they are sensitive to hydrogen and CO2 changes in extracellular fluid.
When there is a high level of CO2 in the blood, an inspiration is triggered to promote ventilation
(Li & Nattie, 1997; Lindsey, Ott, Nuding, Segers, O'connor, & Morris, 2011).
The ventilation processing system includes respiratory neurons located within the
brainstem and spinal cord; they receive mechanical information from the lungs and chemical
information from hemoglobin and blood buffers (West, 1995). The incoming pulmonary afferent
information is vagally mediated and processed by second order interneurons in the (NTS) (Kubin,
Alheid, Zuperku, & McCrimmon 1985, 2006). Motor drive is then provided to the chest

Figure 1.1. Schematic that combines the function of the mechanoreceptors and
chemoreceptors with basic input-processing-output systems.*
*Input-processing-output schematic generated from material on respiration (Buchanan, 2013).
wall (Shiba, 2007). The output system includes respiratory muscles, lung and chest wall, alveolar
9

capillary membrane and hemoglobin and blood buffers (West, 1995).
Ventilation is a complex and carefully orchestrated process involving the coordination of
peripheral and central processes; it sustains life. The respiratory musculature also supports and
produces other airway protective behaviors including cough and swallow. For a successful cough
and swallow to occur, both functioning peripheral and central processes must be coordinated
with eupnea. It has been shown that cough and eupnea share similar premotor neuron firing
patterns during eupnoea and cough (Baekey, Morris, Gestreau, Li, Lindsey, & Shannon, 2001).
Successful coughing and swallowing also require the appropriate functional anatomy and
musculature. Understanding the neural and physical alternations of breathing for cough and
swallow allow for the proper evaluation and treatment of disordered cough and swallow. The
following sections will review the mechanisms of cough and swallow as alterations from the
basic breathing rhythm.
Cough
Cough is vital behavior that assists in preserving the gas-exchange function of ventilation by
clearing foreign material such as aspirate (any inhaled matter or secretions) (Dicpinigaitis, 2007;
Widdicombe & Fontana, 2006); the motor act of a cough can be triggered at multiple locations
within the upper areodigestive and respiratory tracts a such as, the larynx, trachea, or bronchi.3 The
European Respiratory Society (ERS) states that cough is a “three-phase motor act” (Morice et al.,
2007, p. 1256). An effective cough requires high velocity airflow and that airflow usually results
from three phases: 1) inspiration; 2) compression; and 3) expulsion (Castillo & Pitts, 2013; Fontana

3

(Bolser, 1991; Bolser & Davenport, 2000; Bolser, Degennaro, O'reilly, Chapman, Kreutner,
Egan, & Hey, 1994; Forsberg & Karlsson, 1986; Gestreau, Milano, Bianchi, & Grelot, 1996; Jakus,
Poliacek, Halasova, Murin, Knocikova, Tomori, & Bolser, 2008; Pitts, 2012; Poliacek, Wang,
Corrie, Rose, & Bolser, 2010; Rose, Pitts, Poliacek, Davenport, Morris, & Bolser, 2011).
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& Widdicombe, 2007; Pitts, Bolser, Rosenbek, Troche, Okun, & Sapienza, 2009; Pitts, Bolser,
Rosenbek, Troche, & Sapienza, 2008; Pitts, Morris, Segers, Poliacek, Rose, Lindsey, Davenport,
Howland, & Bolser, 2016; Pitts, Rose, Mortensen, Poliacek, Sapienza, Lindsey, Morris,
Davenport, & Bolser, 2013a; Smith Hammond C.A. , 2001; Smith Hammond, Goldstein, Horner,
Ying, Gray, Gonzalez-Rothi, & Bolser, 2009).
During inspiration the diaphragm and chestwall muscles (parasternal and external intercostals)
contract to rapidly increase lung volume (Hanacek, Davies, & Widdicombe, 1984; Langlands,
1967; Lavietes, Smeltzer, Cook, Modak, & Smaldone, 1998; Loudon & Shaw, 1967; Mccool,
2006). Next, the vocal folds come together (adduct) and expiratory muscles contract; this is
referred to as the “compression phase” and at this time, subglottic pressure increases (Mccool,
2006). Abduction of the vocal folds marks the beginning of the expiratory phase. The expiratory
muscles continue to contract generating high airflow rates that may reach up to 12 liters per second
(L/s) in normal healthy adults (Langlands, 1967). Cough is a vital airway protective behavior and
can be initiated via laryngeal and tracheal sensory afferents via a brainstem pattern generator
(Morris, Arata, Shannon, & Lindsey, 1996; Mutolo, Cinelli, Bongianni, & Pantaleo, 2014;
Poliacek, Corrie, Rose, Wang, & Bolser, 2008; Poliacek, Rose, Corrie, Wang, Jakus, Barani,
Stransky, Polacek, Halasova, & Bolser, 2008).
The production of cough may appear rudimentary to novel observers, however it is a very
complex motor act involving the coordination of multiple physiological systems as well as
neurological networks. Understanding of the neural bases of cough and motor output drive is
necessary in order to effectively target pharmacological treatment and/or to manage impaired
cough (Mutolo, Bongianni, Cinelli, Fontana, & Pantaleo, 2008; Poliacek, Plevkova, Pitts,
Kotmanova, Jakus, & Simera, 2016; Shannon, Baekey, Morris, Nuding, Segers, & Lindsey, 2004).
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Cough is a vagally mediated behavior, which can be activated by myelinated and non-myelinated
vagal afferent nerves; it is diminished by anesthesia and eliminated by vagotomy (Canning,
Mazzone, Meeker, Mori, Reynolds, & Undem, 2004; Canning, Mori, & Mazzone, 2006).
Peripheral afferent fibers detect stimuli in the laryngeal and pulmonary mucosa. Data based
on in vivo cat, rabbit and guinea pig models indicate that non-myelinated C-fibers (specifically in
the carina) respond to chemical irritants (Sant'ambrogio, Sant'ambrogio, & Davies, 1984).
Messages are sent ascending through the dorsal root ganglion to second-order neurons in the
nucleus tractus solitarius (NTS) (Kubin, Alheid, Zuperku, & Mccrimmon, 2006; Kubin, 1985).
Central pattern generators (CPGs), or groups of neurons in the brainstem and medulla, respond to
incoming sensory information and regulate descending neural drives. Pontine and medullary
respiratory neurons send descending motor drives to muscles of inspiration and expiration for
production of the cough. The neurophysiology of cough requires precise temporal activation and
suppression of neural networks (Bolser, Poliacek, Jakus, Fuller, & Davenport, 2006).
Two distinct types of defensive reflexes of the respiratory tract are described throughout
the literature: 1) cough (Leith, 1977), and the 2) expiration reflex (Williams, 1841). Although both
reflexes can be induced by mechanical and chemical irritation to the aerodigestive and respiratory
tracts, they differ in the sensory pathway that are activated within the brain and also the central
nervous system circuits which control the behaviors (Widdicome & Fontana, 2006). Cough and
expiration reflex also differ in terms of the presence of a pre-explosive inspiratory phase.
Expiratory reflex does not have the inspiratory effort prior to the expulsion of air.
Swallow
Swallowing encompasses the integration of a complex sensory and motor system that is
under both reflexive and voluntary control. Normal swallowing is a continuous series of events
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that scientists and clinicians conceptually divide into “phases”; these three phases are: oral
prepatory, oral, pharyngeal, and esophageal (Doty, 1968; Logemann, 1984; Miller, 1982). Some
literature report a pre-oral prepatory phase prior to mastication, where neural activity begins and
the body anticipates bolus (material swallowed) delivery (Leopold, 1997). Single and consecutive
swallow events require precise temporal integration of neural activity and muscle movements; with
this, muscle movements within the throat are coordinated and permit food and liquid to flow
through the pharynx and into the esophagus (food pipe). The process of swallow and the associated
motor movement of the oral structures and larynx have been well defined in the literature (Doty,
1956) as a series of chambers and valves that participate to allow for safe passage of a bolus
through the oral cavity and pharynx and then safely into the esophagus (Dodds W.J, 1990; Kahrilas
& Logemann, 1993; Logemann, 1998; Olthoff, Zhang, Schweizer, & Frahm, 2014).
During the pharyngeal stage of swallow, the soft palate elevates to meet the pharyngeal
wall; this velopharyngeal valve closes off the passageway to the nasal cavity and allows for buildup
of pressure within the pharynx (Kahrilas, 1993; Logemann, 2007). Following elevation of the
pharynx, the larynx elevates through contraction of submental muscles which move the hyoid bone
superiorly and anteriorly; subsequently, three levels of laryngeal airway protection ensue
(Logemann, 1984). Multiple valves begin to close off the passage to the airway as food or liquid
passes through the pharynx (Logemann, 2007). The pharyngeal phase of swallow is described as
the following behavioral sequence: 1) the epiglottis inverts; 2) the ventricular folds and arytenoid
cartilages move to a medial position; 3) the vocal folds adduct, sealing the passage to the to the
airway within the larynx (Logemann, 2007); and 4) the superior portion of the esophageal sphincter
(UES) relaxes (Kahrilas P.J., 1988; Logemann, 1984, 2007). These actions result in the bolus
passing through the UES into the esophagus completing the pharyngeal phase.
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A single swallow takes less takes less than 2 seconds to complete and within that time,
twenty-six pairs of muscles and five cranial nerves coordinate sensory and motor actions. The
neurologic network underpinnings of swallow are not completely understood; however, brainstem
control of the swallowing process has been investigated in vivo (Gestreau, 1996; Mogoseanu,
1993, Jean, 2001). The neural network for swallowing is sophisticated and involves carefully
organized connections between respiratory and cough neural networks (Gestreau, 1996; Pitts,
2012).
Mechanisms of a swallow central pattern generator (CPG) are discussed in the literature as
an organization of central control of swallowing (Ertekin & Aydogdu, 2003). The swallow CPG
is located in the brainstem and is comprised of two distinct areas, dorsal and ventral. The dorsal
population is within nucleus tractus solitaries (NTS) and while the ventral swallow group is a
group of pre-motor neurons within the nucleus ambiguous (NA) (Ertekin & Aydogdu, 2003). This
extensive network provides control and regulation of over the swallow process (Ertekin &
Aydogdu, 2003) both augmenting and decrementing-descending motor drives to muscles. Premotor neurons relay information to motor neurons, which in turn send drives to muscles. “Behavior
control assemblies” or BCAs represent additional networks within the system that are theorized to
regulate processes of respiration, cough, and swallow by overriding CPGs (Bolser, Poliacek, Jakus,
Fuller, & Davenport, 2006). It is suggested that, if there is a disruption to the peripheral-sensory,
central-neural motor, anatomical-structural mechanisms, or a combination of each, then the
swallow behavior will be disordered.
Cough and Swallow: Shared Neural and Anatomical Space
Cough and swallow are remarkably coordinated behaviors both in terms of neuronal
activity and shared anatomical structures. As aforementioned, afferent (sensory) information is
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being processed in the NTS which activates the central generators. The CPG then drives the premotor and motor neurons-activate muscles stimulating the superior laryngeal nerve to produce
both cough and swallowing. Evidence shows that there are both shared neural and anatomical sub
straights; a shared NTS (Gestreau, 1996); shared pre-motor neurons (Shiba K., 2007) and muscle
activity (Pitts, Rose, Mortensen, Poliacek, Sapienza, Lindsey, Morris, Davenport, & Bolser,
2013b). Below is a review of these interconnectivities.
Neuronal Activity
Neural networks and activation patterns for breathing, cough, and swallow have both
shared and distinct properties (Dick, Oku, Romaniuk, & Cherniack, 1993; Gestreau, 1996). As
previously discussed, CPGs in the brainstem regulate the process of eupnea. CPGs must be flexible
in their connectivity to allow for rapid change between behaviors of breathing, swallowing, and
coughing. Coordination and/or presence of both cough and swallow has been proposed as being a
“meta-behavior” (Pitts, Rose, Mortensen, Poliacek, Sapienza, Lindsey, Morris, Davenport, &
Bolser, 2013b) in that a central control system coordinates the motor output of the distinct CPGs
for either a cough behavior or swallow. Jean (2001) proposed that the shared CPG for swallow and
breathing is located within the brainstem in the area of the nucleus ambigus (NA), dorsal
respiratory group (DRG), and ventral respiratory group (VRG). Evidence of a flexible neural
system was discovered as Gestreau and colleagues (1996) examined the intracellular response of
33 neurons in the DRG during fictive swallowing. In the experiment by Dr. Gestreau and
colleagues, superior laryngeal nerve (SLN) afferent fibers were stimulated to produce a fictive
swallow. DRG neurons exhibited swallow-related burst activity in response to SLN stimulation
(Gestreau et al., 1996). Results indicated that neurons in this region might be “flexible” in their
functions and adapt to incoming stimuli. Rapid timing between changes from swallow to cough
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behavior offer further evidence of shared and flexible underpinnings (Bolser, 2002). Authors
describe the multi-synaptic connections within respiratory neural networks that allow for the
prompt behavior selection; coughing immediately in response to tracheal irritants such as
aspiration.
Neurons that are firing during respiration have also been shown to fire during swallow.
Bulbospinal inspiratory modulated neurons in the nucleus tractus solitaries (NTS) are depolarized
(making the cell positively charged) and exhibit burst activity during swallowing (Bautista, 2014;
Jean, 2001). Propriobulbar inspiratory modulated neurons also are activated during swallow
(Gestreau et al., 1996). This inspiratory neuronal activity may be responsible for the
“shluckatmung” (Spearman, 2014). The “shluckatmung” is a term for the “swallow breath,” which
is a burst of phrenic activity during swallow (Spearman, 2014). Evidence of the shluckatmung was
shown by EMG recordings of increased parasternal activity and neuroanatomical connectivity
related to the behaviors of cough and swallow in the feline model (Pitts, Rose, Mortensen,
Poliacek, Sapienza, Lindsey, Morris, Davenport, & Bolser, 2013b). This has also been shown in
humans and goats (Feroah, Forster, Fuentes, Lang, Beste, Martino, Pan, & Rice, 2002; Hardemark
Cedborg, Sundman, Boden, Hedstrom, Kuylenstierna, Ekberg, & Eriksson, 2009).
Higher order cortical processing may also be a part of the shared coordination of the neural
systems. Computational modeling incorporating shared cortical networking components has
derived motor activity outputs resembling in vivo studies (Olthoff, Zhang, Schweizer, & Frahm,
2014). The models elucidate additional shared networks participating in the coordination of
swallow and cough behaviors.
Anatomical Structures
Breathing, swallowing, and cough share common anatomy. As the central pattern generator
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within the brain evaluates information regarding the quality of the swallow (i.e., if the swallow is
safe or unsafe), motor activation within respiratory muscles change (Pitts et al., 2013). Peripheral
afferent fibers lining the mucosa of the larynx and trachea detect aspiration by informing the
swallow CPG (Pitts, Morris, Lindsey, Davenport, Poliacek, & Bolser, 2012). The pharyngeal
muscles have been described as having a dual role including as a passive participant in the
movement of food through the pharynx as well as functioning as a sensory feedback system for
cough production (Pitts et al., 2013). Pitts (2013) described suppression of the thyropharyngeus
muscle activity during cough in an animal model and proposed that this activity is meant to protect
the airway by collecting food and liquid that has not been completely expelled.
The “dual valve hypothesis” proposed by Pitts and collogues (2013) is based on a
mechanism within the brainstem control network that prepares the pharynx (swallow modulated
muscles) for cough behavior. These researchers suggest that the upper esophageal sphincter (UES)
and larynx act together to coordinate thyropharyngeus suppression. During a swallow the glottis
is closed and the UES is open allowing passage of bolus material (Logemann, 1985, 2007; Pitts,
2013); this seals the trachea for airway protection and maintains pressures for passage of bolus
material. During the compression phase of cough, both the larynx and UES are maximally closed
and this closure maintains intrathoracic pressure to promote the effectiveness of a cough (Pitts, et
al., 2013).
Examination of temporal musculature relationships between cough and swallow behaviors
has been studied in vivo (Pitts et al, 2013). Bipolar fine-wire electrodes were used to obtain
electromyograms (EMGs) in conjunction with esophageal pressures; wires were placed in seven
muscles to assess the presence of cough and swallow behaviors (Pitts et al., 2013). Mechanical
stimulation to the trachea induced cough and injection of water into the pharynx induced swallow;
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tracheal aspiration was induced with a water bolus presentation (Pitts et al., 2013). Results of this
study showed that, after introduction of water to the oropharynx, cough EMG recordings had
significantly greater amplitudes from parasternal, rectus abdominis, and thyropharyngeus muscles
as well as positive esophageal pressure (Pitts et al., 2013). Abdominal muscle activation during a
swallow activity provided evidence of shared physiological processes. This study was the first to
show alteration of the posterior pharyngeal constrictor during cough, exhibiting the physiological
coordination of mechanisms between cough and swallow.
“Behavior selection” is the concept that airway protective decision making, which occurs
via afferent feedback, occurs on a moment-by-moment basis (Bolser, Pitts, & Morris, 2011). It is
suggested that actions that require little central processing take “precedence” over centrallymediated processes and can block centrally-mediated behaviors until the brainstem-controlled
behaviors are completed. Thus, the brainstem-controlled swallow action may take precedence over
centrally-mediated breathing. The apneic period (moment of not inhaling/exhaling during a
swallow) is evidence of pattern selection.
Foundational knowledge of the neural and physiological underpinnings of breathing,
swallowing, and coughing is essential to understand dystussia in patient populations. Even in the
absence of brainstem impairment, neurogenic populations that have both upper and lower motor
neuron dysfunction may exhibit concurrently impaired cough and swallowing (Hegland, Okun, &
Troche, 2014; Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008; Plowman, Watts, Robison,
Tabor, Dion, Gaziano, Vu, & Gooch, 2016; Smith Hammond, 2001).
Gating of Airway Protective Behaviors
Central processing of afferent stimuli can significantly modify cough and swallow
excitability. This action is termed “gaiting” (Bolser, Poliacek, Jakus, Fuller, & Davenport, 2006),
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and can result in hyper- and hypo-excitability of the cough (Morice, Jakes, Faruqi, Birring,
Mcgarvey, Canning, Smith, Parker, Chung, Lai, Pavord, Van Den Berg, Song, Millqvist, Farrell,
Mazzone, & Dicpinigaitis, 2014). Although gaiting is often considered to be under automatic
control, we are beginning to understand that the cortex can significantly modulate cough
excitability (Vertigan, 2008). Davenport and colleagues (2008) demonstrated that in response to a
reflexive cough challenge all subjects first experience a sensation. The authors then went on to
measure this sensation termed the “Urge to Cough”. They ultimately proposed that supramedullary
(cortical) input to the brainstem cough CPG is intimately involved in the ultimate magnitude of
the cough motor response.
The conclusions of many animal-model studies are consistent with the premise that motor
control of cough is under automatic control from brainstem CPGs. However, the “Urge-to-Cough”
model (Davenport, 2008) presents a representation of a feedback loop, which supports the presence
of a cortical component of the cough system.
“There are six stages to the cough ‘motivation-to-action’ model: 1) stimulus - trigger for
neural event; 2) urge - the physical need to respond; 3) desire - translation of urge to a
central neural targeted goal; 4) action - physical response that satisfies the urge-desire; 5)
evidence - feedback to the neural system on the action; and 6) reward - sensory system that
determines if the urge was satisfied (Davenport, 2008, p. 107)”.
Taking into account the motivation-to-action model, researchers have studied higher-level cortical
involvement, or the conscious decision making during the production of a cough. Hegland et al.
(2012) administered capsaicin to 20 healthy adults; they were asked to modify their cough response
including shorter/softer and longer/louder coughs. Results showed that individuals could
voluntarily modify the reflexive behavior even under exposure to irritants (Hegland et al., 2012).
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Additional evidence to support a cortical component to cough regulation includes a blunted
affernet C-fiber response to stimulation in an anesthetized, in vivo preparation (Moreno-Lopez,
Perez-Sanchez, Martinez-Lorenzana, Condes-Lara, Rojas-Piloni, 2013). The ability to voluntarily
gate a response to sensory stimuli implies cortical processing of the cough response in humans.
Descending motor drive signals are activated in a graded manner (Davenport, 2008).
Depending on the strength of the stimulus, either a high concentration of an irritant or verbal
instruction to produce a “strong cough,” the resulting cough behavior will be related to the stimulus
(Davenport, 2008). Therefore, it is essential to note that the specific directions given to human
subjects when eliciting a voluntarily induced cough may be related to the strength of voluntary
cough production.
Dystussia and Cough Measurement
The presence of dystussia has multiple negative health implications in a variety of patient
populations (Nakajoh K., 2000). Understanding cough as it is related to airway safety in a variety
of clinical populations will have major health care implications as we can possibly detect early
signs of swallowing impairment or rehabilitate cough for improved airway protection. It is an
advancing area of research in both the basic science and clinical science research realms. Cough
production is a measurable physiologic phenomenon. Objective measures of cough can be obtained
using different elicitation methods such as inducing a reflexive cough or prompting a voluntarily
induced cough. Cough evaluation tools include cough monitors, perceptual assessment, evaluating
acoustic characteristics, and physiologic measurement. Each evaluation tool and cough elicitation
method provides unique and valuable objective information about cough function.
Reflexively and Voluntarily Induced Cough
Elicited or induced cough is frequently tested with flow dosimeters or nebulizers to
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administer irritant gases; these irritants may include but are not limited to capsaicin, citric acid
aerosols, and fog (Fontana & Widdicombe, 2007). This methodology directly evaluates
responsiveness of the afferent system. Induced cough is often associated with an expiratory reflex
as there may be an absent or reduced inspiratory effort. Binary outcomes (present/absent) of cough
production are typically recorded as well as quantifying the number of coughs produced, and time
to cough production. Recording airflow waveforms produced during a cough effort may also be
coupled with the administration of irritants.
Voluntary cough is acquired by having the patient cough upon command to a verbal
stimulus. It consists of a multistage event including an inspiration, closure of the vocal folds during
a compression phase, and a forced expiration. Possible outcome measures include objective
airflow measures, subjective ratings, and acoustic properties.
Airflow Measurement
Both induced and voluntary cough assessment methods allow for the acquisition of cough
airflow data. Airflow data allows the clinician/researcher to gather information regarding the
function of the respiratory system. Airflow values are dependent upon a number of variables
including stimulus, laryngeal closure (build-up of subglottic pressure), expiratory muscle activity
(Widdicombe, 2006) and in some cases inspiratory effort. Airflow waveforms are recorded by
using an oral pneumotachograph, a device that measures rate of airflow, connected to a spirometer
(pressure transducer) that then sends signals to a recording system to display waveforms on the
computer (Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008; Smith Hammond, 2001). Cough
production is recorded as a measure of airflow in liters (L) over time in seconds (L/s). Typical
measures derived from the waveforms include temporal aspects of the cough, amplitude in L/s,
and volume of expired airflow.
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As illustrated in Figure 1.2, common objective measures of cough production that have
been reported in previous research studies include, but are not limited to, inspiratory phase duration
(IPD), inspiratory peak flow (IPPF), compression phase duration (CPD), expiratory peak flow
(EPPF), expiratory rise time (EPRT), and cough volume acceleration (CVA); these terms are well
described throughout the cough literature. CVA is described in the literature as a measure that is
thought to be indicative of cough effectiveness (Bolser, 2002; Fontana & Lavorini, 2006; Smith
Hammond C.A., 2001). To obtain outcome measures, waveforms are analyzed by identifying
physical landmarks on the cough waveform. Data points are recorded and a series of calculations
are made to obtain the final value for each objective measure.

Figure 1.2 Same as Figure 2.1 which has been previously published in Watts et al, 2016, p.
268, “Example of voluntary cough waveform measured with cough spirometry. Select derived
objective measures are delineated on the waveform including: A) inspiratory phase duration;
B) inspiratory peak flow; C) compression phase duration; D) peak expiratory flow rate; and E)
22

cough expired volume. Expiratory rise time is calculated by subtracting time at end of
compression from peak expiratory flow time. Cough volume acceleration is not depicted but is
calculated by dividing peak expiratory flow rate by the expiratory rise time.”

Although testing methodology differs between elicited and voluntary cough, researchers
suggest that airflow patterns of voluntary cough are similar to reflexive cough (Widdicombe &
Fontana, 2006). When a cough is elicited by either an irritant or verbal command, there is a
cognitive awareness of a need to cough; this is termed, “Urge-to-Cough” (Davenport, 2009).
Authors suggest that this implies that cough has been activated via cortical neural pathways;
specifically, the super pontine pathways have activated and the cognitive aspect of awareness and
the urge precedes the behavior response in both elicited and voluntary cough (Hegland, Bolser, &
Davenport, 2012).
Sound Characteristics
As cough is an audible physiologic event, acoustic and auditory perceptual characteristics of
cough have also been investigated. Current methods that have been employed in current practice
include a sound level meter to measure the sound pressure level (dB SPL) associated with a cough.
In addition, cough has been characterized by having a rater listen to a cough and make subjective
ratings (Laciuga, Brandimore, Troche, & Hegland, 2016). Subjective ratings of auditory perceptual
characteristics of cough include but are not limited to: bovine, inadequate, weak, strong, wet, dry,
productive, barking, hacking, present or absent. There is little consensus as to what these sound
characteristic imply about the physiologic mechanism producing the cough.

Furthermore,

perceptual ratings are limited by the arbitrary and or ordinal nature of the ratings and can be
strongly biased by context while lacking desirably high inter- and intra-rater reliability (Shrivastav,
2005).
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Cough monitors vary in design and employ the use of a microphone in an attempt to
objectively measure how many times the subject coughs in a given period of time. The recordings
acquire an acoustic cough waveform. The European Respiratory Society (ERS) guidelines state
that, for the assessment of acoustic recordings, cough is defined as “a forced expulsive maneuver
or maneuvers against a closed glottis that are associated with a characteristic sound or sounds”
Acoustic recordings of cough are quantified in a number of ways: 1) explosive cough sound
(counting the explosive sounds waves); 2) cough seconds (time spent coughing); 3) cough breaths
(how many coughs occur within breath group); and 4) cough epochs (cough sound that continues
without a 2-s pause) (Morice et al., 2007).cough epochs (cough sound that continues without a 2s pause) (Morice et al., 2007).
Dysphagia
Dysphagia refers to difficulty swallowing and results as a symptom of a medical diagnosis
rather than an etiology. Medical diagnoses that may lead to dysphagia include: neurologic
diagnosis, connective tissue or rheumatoid disorders, structural diagnosis (e.g., tumors), Iatrogenic
diagnoses, respiratory compromised conditions, esophageal disorders, and psychogenic conditions
(Groher & Puntil-Sheltman, 2010). There is a reportedly wide range of patients (52-82%) with
neurodegenerative diseases that are affected by oropharyngeal dysphagia (Clavé, 2004).
Symptomology of dysphagia may include a combination of prandial (i.e., during
swallowing) and post prandial coughing or choking, nasal or oral regurgitation of food or liquid,
odynophagia (painful swallowing), labial spillage, unexplained weight loss, nutritional
deficiencies (Groher & Puntil-Sheltman, 2010), halitosis, or sensation of food/pills getting “stuck”
within the throat.
Dysphagia impacts health, quality-of-life, and increases a patient’s financial burden (Da Costa
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Franceschini & Mourao, 2015; Leow, Huckabee, Anderson, & Beckert, 2010; Maclean, Cotton, &
Perry, 2009; Plowman-Prine, Sapienza, Okun, Pollock, Jacobson, Wu, & Rosenbek, 2009; Tabor,
Gaziano, Watts, Robison, & Plowman, 2016) Subsequent aspiration pneumonia (lung infection)
from severe untreated or unmanaged dysphagia constitutes a serious health concern (Delegge,
2002). Aspiration in already medically compromised patients may lead to decreased hospital
outcome and may cause death (DeLegge, 2002). In fact, dysphagia is associated with pulmonary
sequelae and a leading cause of death in Parkinson’s disease (PD) (Hoehn & Yahr, 1967) and
attributes to mortality in Amyotrophic Lateral Sclerosis (ALS) (Czaplinski A., 2006).
Clinical Evaluation of Dysphagia
Dysphagia assessment involves a variety of health professionals (Groher M.E., 2010).
There are both clinical and instrumental (using high-tech instrumentation) approaches to dysphagia
assessment. The “gold standard” instrumental assessment involves performing the Modified
Barium Swallow Study (MBS) (Logemann, 1984). The MBS is a fluoroscopic imaging study in
which the patient is given barium, an inert radiographic substance, to swallow and bolus flow
through the oral cavity and pharynx are visualized. Other instrumental evaluation includes the
Fiberoptic Endoscopic Evaluation of Swallowing (FEES). This methodology requires the clinician
to pass a scope trans-nasally to view the laryngeal vestibule during swallowing tasks.
Instrumental swallow evaluation affords direct visualization of the swallow process and
thus, in the hands of a skilled clinician, can lead to an accurate diagnosis of oropharyngeal
impairment. Assessment that does not require the use of instrumentation or radiography includes
various non-instrumental clinical evaluations. The terms clinical swallow examination (CSE), or
bedside swallow examination (C/B E) is used to describe this type of assessment (McCullough,
2001, Logemann, 1984).
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The CSE can be performed at the patient’s bedside but is not restricted to the bedside
(Groher M.E., 2010) and does not include internal visualization of the swallow mechanism. CSE
are widely used by SLPs to assess patients who are suspect of having oral or oropharyngeal
dysphagia. During a CSE, clinicians carefully examine the structure and function of the oral
mechanism and evaluate the oral phase of swallowing. Patients are commonly asked to complete
a series of both swallowing and non-swallowing tasks; based on the patient’s performance,
clinicians make determinations regarding swallow safety and the pharyngeal phase of the swallow.
There are three main components to the CSE: 1) the medical history 2) physical inspection
of swallow anatomy and musculature 3) swallow trials (Logmann 1984, Groher M.E., 2010). The
purpose of the CSE is to accurately detect the presence or absence of a disordered pharyngeal stage
of swallow without direct internal visualization of the anatomy. Instead, “clinical signs” are used
to detect the presence of penetration or aspiration. The clinical assessment of swallow may consist
of variations of these three main components. Several studies outline the predictive values of these
measures in specific patient populations.
Dysphagia, Dystussia, and Airway Protection
Cough is a vital airway protection mechanism during swallowing; it acts as a sweeping
mechanism to clear the lower airways of aspirant material (Bolser, 2002; Pitts, 2012; Smith
Hammond C.A., 2001). Dystussia decreases an individual’s ability to protect their airway and thus,
in certain neurogenic populations, can increase the risk for aspiration, dysphagia, subsequent
aspiration pneumonia, and morbidity (Smith-Hammond 2009; Pitts, 2010). Normally, the cough
reflex is an audible clinical indicator of aspiration. Therefore, the absence of a cough reflex in the
event of aspiration may be an indicator of impairment (Pitts, 2013) as this may indicate poor
sensory feedback response. Clinically, dystussia has been described in neurodegenerative disease
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populations such as Parkinson’s disease (PD) (Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008,
2010), stroke (Smith-Hammond et al., 2001; Smith-Hammond et al., 2009), and Amyotrophic
Lateral Sclerosis (ALS) (Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016).
Both respiratory and swallowing impairments are highly prevalent in individuals with Parkinson’s
disease (PD) and Amyotrophic Lateral Sclerosis (ALS).
Although it appears that voluntary cough production is related to airway protection status
during swallowing in neurodegenerative disease populations, the methodology to test cough
objectively is costly and the analysis labor intensive, time consuming, and requires intensive
training to perform expert evaluation of physiologic cough waveforms. The current voluntary
cough testing methodology is not a feasible method to utilize in busy clinic environments.
Methods available to assess cough during a clinical swallowing evaluation without the use of
airflow recordings include evaluating the strength of a cough (Daniels, 1998; Laciuga,
Brandimore, Troche, & Hegland, 2016; Mccullough, 2001). This relies on the perception of
“strength” and there is a lack evidence to support the reliability and validity of perceptual
evaluation of voluntary cough (i.e., strength) for the purpose of clinically assessing swallowing
function and airway protection mechanisms. While current clinical evaluation of cough is focused
on cough frequency (how many times a person coughs), cough reflex testing (often using tussive
agents), voluntary cough measures, and patient subjective ratings of severity, little is known
regarding the reliability or validity of clinician perceptions of voluntary cough effectiveness or
auditory characteristics of cough. Therefore, clinicians may not have the necessary tools to
describe impaired cough, and its role in dysphagia screening may be currently underutilized.
Critical research questions to address include: 1) what clinical swallowing assessments are
available to assess cough; 2) what voluntary cough assessment methods are speech language
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pathologists using in their clinical practices; 3) what physiologic features of cough are useful in
determining the presence of a swallowing disorder; 4) what, if any, novel, objective, acoustic
parameters of voluntary cough are useful in detecting the presence of a swallowing disorder?
The relevance of such work is paramount for professionals who serve populations with
impaired swallow ability as traditional methods of clinical swallowing assessment often fail to
identify those with impaired swallowing who silently aspirate (i.e., no reflexive cough). Current
binary subjective measures (i.e., strong/weak) used during clinical swallow assessments fail to
provide quantitative data or describe deviant auditory features of cough. There remains a need to
investigate novel methodologies to assess voluntary cough in humans for the purposes of
evaluating swallowing dysfunction. The results of such studies may lead to more sensitive and
specific means of speech-language pathologist’s clinically assessing swallow function and may
provide better health outcomes for patients. Although there are studies that focus on the
relationship between cough and swallow, there is a paucity of data on clinician reliability of
assessing cough function, or deviant audible features of dystussia which may inform clinicians of
decreased airway protection.
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CHAPTER TWO:
TO COUGH OR NOT TO COUGH? EXAMINING THE POTENTIAL UTILITY OF
COUGH TESTING IN THE CLINICAL EVALUATION OF SWALLOWING

Note to Reader
This article has been previously published in Current Physical Medicine Rehabilitation
Reports, 2016, 4: 262-276, and has been reproduced with the permission of Springer Publishing
(Appendix A).
Introduction
Dysphagia (impaired swallowing) impacts the ability of an individual to consume oral
intake safely and efficiently. Dysphagia accounts for approximately 7% of hospital admissions in
the United States (Altman, 2011; Altman, 2010) and is estimated to have a total economic burden
of approximately $547 million dollars per year (Cichero, 2012). Impairments in swallowing
efficiency refer to difficulties transporting foods and liquids from the oral cavity into the stomach
that result in residue in the oral cavity, pharynx, and esophagus, and that are linked to malnutrition
(Moreira, 2016). Impairments in airway safety occur when ingested foods or liquids enter the
airway (i.e., penetration or aspiration) and are linked to increased pneumonia risk (Cabre, SerraPrat, Force, Almirall, Palomera, & Clave, 2014). The inability to eat or drink by mouth is
associated with reductions in mental well-being, quality of life, and increased caregiver burden
(Cichero, 2012; Leow, Huckabee, Anderson, & Beckert, 2010; Maclean, Cotton, & Perry, 2009;
Paris, Martinaud, Hannequin, Petit, Cuvelier, Guedon, Ropenneck, & Verin, 2012; Plowman29

Prine, Sapienza, Okun, Pollock, Jacobson, Wu, & Rosenbek, 2009; Tabor, Gaziano, Watts,
Robison, & Plowman, 2016). These life-threatening and psychosocial sequelae of dysphagia
necessitate timely and accurate identification of swallowing impairment in at-risk individuals to
optimize safe oral intake, pulmonary health, and quality of life.
Evaluation of swallowing begins with a “bedside” or clinical swallow examination (CSE).
The CSE typically includes a review of patient history, patient-reported symptoms, assessment of
the oral mechanism, and observation of liquid and food swallowing trials (Suiter, 2012).
Subsequent instrumental evaluation may be performed at the clinician’s discretion, if clinical signs
or symptoms warrant further evaluation, and pending the availability of resources. The
Videofluoroscopic Swallow Study (VFSS) represents the gold standard instrumental swallowing
assessment. It constitutes the only type of assessment with direct visualization of both the oral and
pharyngeal phases of swallowing to confirm specific impairments in swallowing that maybe
suspected during the CSE, and affords the ability to determine specific contributing mechanisms
of oral, pharyngeal and often esophageal stage impairments (Logemann, 1984). Although VFSS
represents the gold standard instrument, many clinicians may rely solely on the CSE given limited
or no access to VFSS (Association, 2000). Another instrumental evaluation technique, the
fiberoptic endoscopic evaluation of swallowing (FEES), is a useful tool in providing a 3dimensional visualization of the pharyngeal stage of swallowing. FEES is noted to provide
superior and direct imaging of pharyngeal anatomy, secretions, and vocal fold movement, however
is limited in its application in many settings due to access to equipment and skill level of the
clinician.
Since the CSE does not permit direct visualization of the swallowing process, its ability to
accurately identify individuals who ‘silently’ aspirate (i.e., no cough in response to material
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entering airway) has been identified as a major limitation (Miles, Moore, Mcfarlane, Lee, Allen,
& Huckabee, 2013; Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016; Smith
Hammond, 2008). For example, one study documented that the CSE identified only 30% of
radiographically confirmed aspirators in 107 hospitalized patients (Splaingard Ml, 1988).
Considering this limitation, research has focused on determining the sensitivity and specificity of
various validated clinical tools, screeners and clinical signs to identify dysphagia or aspiration in
order to improve the utility of the CSE (Mccullough & Martino, 2013; Mccullough, 2005, 2001;
Rosenbek, Mccullough, & Wertz, 2004). For example, can tasks identifying poor lingual
movement discriminate safe versus unsafe swallowing? Determining components of the CSE that
accurately detect swallowing safety and efficiency during swallowing is a significant research
initiative and may reduce error during CESs.
Although the American Speech Language Hearing Association (ASHA) provides
guidelines for performing an instrumental evaluation of swallowing (Karen Dikeman, 2003), only
practice recommendations (and no published guidelines) exist for the CSE (Association, 2000).
As a result, current CSE protocols vary widely, and might constitute use of a validated CSE tool
(see Table 2.1) or combinations of various standardized assessments. Further, procedural policies
for conducting a standardized CSE are limited and, given the variability in clinical practice
patterns, dysphagia recommendations and management strategies also vary (Mathers-Schmidt &
Kurlinski, 2003). suggests that cough airflow measures may serve as a useful physiologic metric
to index airway defense capabilities in at-risk individuals (Anna Miles 2013; Hegland, Okun, &
Troche, 2014; Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008; Pitts, Troche, Mann, Rosenbek,
Okun, & Sapienza, 2010; Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016;
Sato, Tohara, Iida, Wada, Inoue, & Ueda, 2012; Smith Hammond C.A. , 2001; Smith Hammond,
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Goldstein, Horner, Ying, Gray, Gonzalez-Rothi, & Bolser, 2009). Cough function has been an area
of increasing interest in the evaluation, management, and treatment of dysphagia (Plowman, Watts,
Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016). This is not surprising given the crucial role
cough serves in defending the airway during swallowing. Indeed, recent research highlights a close
relationship between voluntary and reflexive cough airflow measures and airway safety status
during swallowing; emerging data The purpose of this narrative review is to examine the
relationship between cough and swallow, summarize current validated CSE’s, and review the
discriminant capacity of both voluntary, and reflexive, cough testing to detect unsafe swallowing.

32

33

34

35

Relationship between Cough and Swallow
Cough is a sensorimotor behavior involved in airway protection to forcefully eject foreign
material from the laryngeal vestibule and lower airways (Bolser, 2002; Pitts, 2012; Ross, 1955;
Smith Hammond C.A., 2001). An effective cough is therefore critical in removing aspirate material
from the airway during swallowing, particularly in patients with additional co-morbidities who are
more susceptible to developing pulmonary sequelae. In many neurogenic populations, dystussia
(impaired cough) and dysphagia present in parallel (Hegland, Okun, & Troche, 2014; Pitts, Bolser,
Rosenbek, Troche, & Sapienza, 2008; Pitts, Troche, Mann, Rosenbek, Okun, & Sapienza, 2010;
Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016; Smith Hammond, 2001),
a finding that is not surprising given the shared neural and anatomical substrates of respiration,
cough, and swallowing function (Gestreau, 1996; Pitts, 2012; Troche, Brandimore, Godoy, &
Hegland, 2014).
Central pattern generators (CPGs) in the brainstem regulate the processes of eupnea
(unlabored respiration), swallow, and cough (Davenport, Bolser, & Morris, 2011). The nucleus
ambiguus, dorsal respiratory group, and ventral respiratory group located within the brainstem are
associated with the neural control of the behaviors of respiration, cough, and swallow (Bolser,
2002; Gestreau, 1996; Jean, 2001). Vagal afferent nerves that are both chemically and
mechanically sensitive and non-myelinated c-fibers across multiple afferent beds (J.G., 1998)
provide sensory feedback during swallowing (e.g. bolus volume consistency and volume, presence
of aspirate material in the airway) which then informs the swallow central CPG (Pitts, 2012). The
CPGs are inherently flexible in their connectivity to allow for rapid, on-line modification between
the behaviors of cough, breathing, and swallowing such as, increasing apnea duration due to a
larger swallowed bolus or the execution of a rapid and protective cough in response to aspirated
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material during swallowing (Bianchi & Gestreau, 2009). Changes in respiratory muscle activation
occur as the swallow CPG is informed about characteristics of the swallow (i.e., safe vs. unsafe,
sequential vs. single sip) (Pitts, Rose, Mortensen, Poliacek, Sapienza, Lindsey, Morris, Davenport,
& Bolser, 2013b). Higher order cortical processing or supramedullary input such as sensory
integration and motor planning also provides vital input modulating both cough and swallowing
behaviors. Computational modeling studies performed to determine neural networks of both cough
and swallowing have elucidated shared efferent and afferent pathways involved for breathing,
swallowing and cough (Davenport, Bolser, & Morris, 2011; Pitts, 2012).
Evidence from human studies suggests that supramedullary input is involved in both
voluntary and reflexive cough, with neural processing of stimuli prior to the act of cough resulting
in what Davenport and colleagues (2008) have termed the “Urge to Cough” (Davenport, 2008;
Davenport, Vovk, Duke, Bolser, & Robertson, 2009; Hegland K.W., 2011; Widdicombe, Eccles,
& Fontana, 2006). This cortical regulatory component in humans is supported by the voluntary
suppression of a reflexive cough response (Hegland K.W., 2011). In addition to the established
shared central neurologic substrates, functions of respiration, swallow, and cough also peripherally
share anatomical structures of the upper airway, pharynx, and oral and nasal cavities. Troche and
colleagues (2014) conceptualized a framework for understanding the shared neural and anatomical
substrates of cough and swallow in a comprehensive review on this topic (Troche, Brandimore,
Godoy, & Hegland, 2014). This conceptual framework presents swallowing and cough along a
‘spectrum of airway protective behaviors’, with swallowing at one end of the spectrum (protective
function) and cough at the opposite end (defensive function) (Troche, Brandimore, Godoy, &
Hegland, 2014). Thus, these two sensorimotor acts have highly coordinated and reciprocal
functions with shared anatomical and neurologic underpinnings that provide a mechanistic,
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anatomical and neurologic foundation for considering the role of cough during a clinical swallow
examination.
Clinical Swallowing Evaluation
The main components of the CSE include a thorough medical history review; patient and
caregiver interview of symptoms; physical inspection of the integrity of swallow anatomy at rest
and during movement; and observation of performance on food and liquid swallowing trials
(Logemann, 1984). The CSE is typically completed by a certified Speech-Language Pathologist
(SLP) and performed across a variety of healthcare settings that include, but are not limited to:
acute, sub-acute, and rehabilitation hospitals; specialized outpatient clinics’ skilled nursing homes;
home health care; and assisted living facilities. The objective of the CSE is to obtain information
from the patient’s history, self-reported symptoms and presenting clinical signs to make best
clinical judgments regarding swallowing safety and efficiency and to provide dietary and treatment
recommendations. The CSE plays an important role in patient care and it is critical to accurately
identify patients who may have compromised swallow efficiency and airway safety. Dysphagia
screening is typically implemented more broadly to asymptomatic patients in order to detect a
possible condition (Suiter, 2012). At-risk patient groups (e.g. stroke) are often targeted for
dysphagia screening.
Given the previously identified limitations of the CSE to identify all individuals with
dysphagia, and barriers to use, there exists a critical need for sensitive screening tools to be
incorporated during the CSE (Mccullough, 2001; Plowman, Tabor, Robison, Gaziano, Dion,
Watts, Vu, & Gooch, 2016; Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch,
2016). Given the shared neurologic, anatomic and mechanic roles of cough and swallow, the
potential utility of cough testing in the CSE has been a recent topic of interest to provide
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information regarding mechanisms of airway safety and the physiologic ability of an individual to
defend their airway (Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008; Pitts, Troche, Mann,
Rosenbek, Okun, & Sapienza, 2010; Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, &
Gooch, 2016; Smith Hammond C.A. , 2001; Smith Hammond, Goldstein, Horner, Ying, Gray,
Gonzalez-Rothi, & Bolser, 2009; Wheeler Hegland, Troche, Brandimore, Davenport, & Okun,
2014). Currently, however, cough testing is not routinely incorporated in the CSE across all
settings. There is substantial variability in current practice patterns in the evaluation of swallowing
function (Mcallister, Kruger, Doeltgen, & Tyler-Boltrek, 2016).
Validated Clinical Swallow Evaluations and Screening Tools
Commonly utilized validated clinical swallow protocols include the: Barnes-Jewish
Hospital Stroke Dysphagia Screen (BJH-SDS) (Edmiaston, Connor, Loehr, & Nassief, 2010;
Edmiaston, Connor, Steger-May, & Ford, 2014); Mann Assessment of Swallowing Ability (Mann,
2002); Modified Mann Assessment of Swallowing Ability (MMASA) (Antonios, Carnaby-Mann,
Crary, Miller, Hubbard, Hood, Sambandam, Xavier, & Silliman, 2010); Toronto Bedside
Swallowing Test (TOR-BSST) (Martino, Silver, Teasell, Bayley, Nicholson, Streiner, & Diamant,
2009); Timed Swallow Test (Hinds, 1998); Acute Stroke Dysphagia Screen (ASDS) (Edmiaston,
Connor, Loehr, & Nassief, 2010; Edmiaston, Connor, Steger-May, & Ford, 2014); Gugging
Swallow Screen (GUSS) (Trapl, Enderle, Nowotny, Teuschl, Matz, Dachenhausen, & Brainin,
2007); Yale Swallow Protocol (Suiter, Sloggy, & Leder, 2014); Volume Viscosity Test (Clave,
Arreola, Romea, Medina, Palomera, & Serra-Prat, 2008); Northwestern Dysphagia Patient Check
Sheet (Logemann, 1999); and the 3 oz. Water Swallow (Suiter & Leder, 2008). Table 1 provides
a summary of these published, validated CSEs, with reference to the patient population the tool
was validated for, tool administration, inclusion of cough testing, and any published statistical data
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regarding its discriminant ability to identify dysphagia or unsafe swallowing.
Of the 11 validated CSEs commonly used, 6 were designed to be administered specifically
by Speech-Language Pathologists, 3 to be administered by trained nursing staff, and 1 by
physicians (Logemann et al. did not specify). Review of published reports indicates that the highest
levels of sensitivity (>85%) for detecting aspiration is provided by the BJH-SDS (Edmiaston,
Connor, Loehr, & Nassief, 2010; Edmiaston, Connor, Steger-May, & Ford, 2014), Acute Stroke
Dysphagia Screen (ASDS) (Edmiaston, Connor, Loehr, & Nassief, 2010; Edmiaston, Connor,
Steger-May, & Ford, 2014), Yale Swallow Protocol (Suiter, Sloggy, & Leder, 2014), Volume
Viscosity Test (Clave, Arreola, Romea, Medina, Palomera, & Serra-Prat, 2008), Northwestern
Dysphagia Patient Check Sheet (Logemann, 1999), and the 3 oz. Water Swallow Test (Suiter &
Leder, 2008). However, none of the protocols reach the highest level (>85%) of reported overall
specificity for detecting aspiration. The Modified Mann Assessment of Swallowing Ability, a
physician-administered protocol, provides the highest levels of sensitivity and specificity for
detecting global swallowing impairment (i.e., 92% and 87% respectively).
Of the 11 validated CSEs, 4 (36%) incorporate some form of cough testing. Description of
cough testing methodology varies within the context of each examination. Upon careful inspection
of the published protocols that include cough assessment, specific instructions for eliciting the
cough task are vague, and the subjective perceptual measures of cough vary between protocols.
The MMASA (same tasks as the MASA for cough testing) contains the most detailed instruction
for cough elicitation and perceptual cough judgment. Per protocol, the physician or administrator
asks the patient to ‘cough as strong as possible’ (Antonios, Carnaby-Mann, Crary, Miller,
Hubbard, Hood, Sambandam, Xavier, & Silliman, 2010). Judgments of cough strength and clarity
are rated, with an outcome score is assigned corresponding to one of the following: no abnormality,
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cough attempted but is hoarse in quality, attempt inadequate, no attempt, or unable to perform.
Logemann et al. (1999) described a subjective cough assessment in the Northwestern Dysphagia
Patient Check Sheet, in which administrators judge either a voluntary cough, or throat-clearing
maneuver, and perceptually rated the strength of the behavior. A strong cough/throat clear was
judged as ‘safe’, and weak cough/throat clear was judged as ‘unsafe’ (Logemann, 1999). The
GUSS includes an assessment of ‘voluntary cough’ without reference to specific cough task
instruction; the cough task is rated based on a weak or absent response (Trapl, Enderle, Nowotny,
Teuschl, Matz, Dachenhausen, & Brainin, 2007).
Laciuga and colleagues recently investigated relationships between perceptual ratings of
cough and objective airflow measures of cough (Laciuga, Brandimore, Troche, & Hegland, 2016).
Thirty clinicians (speech- language pathologists, otolaryngologists and neurologists) rated the
subjective parameters of strength, duration, quality, quantity, and overall ‘effectiveness’ of ten
audio recordings of cough containing specific airflow characteristics. Objective physiological
aerodynamic parameters of cough airflow were associated with the clinical perception of cough
strength and effectiveness. The specific parameters that were clinically perceived as strong and
effective included: compression phase duration, peak expiratory flow rate, peak expiratory flow
rise time, cough volume acceleration and total expired volume. Interestingly, only 4 CSE protocols
reviewed here currently utilize perceptual judgment of cough as part of the swallowing
examination, and none include physiologic measures of cough airflow.
Utility of Voluntary Cough Testing in Dysphagia
Voluntary or volitional cough testing involves asking a patient to cough (typical
instructions are: “as hard as you can” or “like have something stuck in their throat”). The resulting
motor output can then be assessed either subjectively by listening, or objectively with specialized
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equipment. For a complete review of the physiologic components of cough, we refer readers to
Smith-Hammond et al. (ref number). Briefly, cough is characterized of three distinct phases:
1) Inspiratory phase: composed of contraction of the external intercostal muscles elevating the
anterior rib cage and drawing down the diaphragm as it contracts (West, 1995) while laryngeal
muscle activation allows for passage of air through the glottis resulting negative pressure drawing
air into the lungs (Bautista, Sun, & Pilowsky, 2012; West, 1995).
2) Compression Phase: during which adduction of the vocal folds builds and maintains subglottic
pressure generation.
3) Expiratory Phase: composed of a forceful and rapid abduction of the vocal folds. Physiologic
cough testing using the gold standard pneumotachograph measures airflow signals across all three
phases that can be subsequently analyzed using specialized software. Objective cough flow
measures can be derived and are illustrated in Figure 2.1 with definitions provided in Table 2.2.
Several investigators have examined relationships between voluntary cough airflow
measures and swallow safety status to elucidate the clinical utility of voluntary cough spirometry
testing in several patient populations (Pitts, Bolser, Rosenbek, Troche, & Sapienza, 2008;
Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016; Smith Hammond C.A. ,
2001; Smith Hammond, Goldstein, Horner, Ying, Gray, Gonzalez-Rothi, & Bolser, 2009).These
are summarized in Table 2.3 and reviewed below.
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Figure 2.1 Example of voluntary cough waveform measured with cough spirometry.
*Select derived objective measures are delineated on the waveform and referenced in Table
2.2 including: A) inspiratory phase duration; B) inspiratory peak flow; C) compression phase
duration; D) peak expiratory flow rate; and E) cough expired volume. Expiratory rise time is
calculated by subtracting time at end of compression from peak expiratory flow time. Cough
volume acceleration is not depicted but is calculated by dividing peak expiratory flow rate by
the expiratory rise time.

Stroke
Smith-Hammond and colleagues (2001) first examined the relationship between objective
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Table 2.2. Definitions of objective voluntary cough airflow measures with reference to
illustrative cough waveform depicted in Figure 2.1. Specific references of published studies
utilizing each measure are also provided.
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Table 2.3 Review of six research studies investigating the significant differences in voluntary
cough measures between unsafe (penetrators and/or aspirators) and safe (non-aspirators)
swallowers in dysphagic populations including Stroke, Parkinson’s disease, and Amyotrophic
Lateral Sclerosis.
First
Author
Year:

Patient Population
Number (N) Studied
Swallowing Safety Groups:

Swallowing Assessment
Method
and Testing Stimuli
Statistical Comparison

· Stroke
· VFSS or FEES (group n is
· N = 43 Stroke; 18 control
not specified)
· 5mL, 15 mL, and unregulated
· Three airway safety
groups:
cup sips of thin liquid, Ensure
Plus, and ‘thickened liquid’
· Severe aspirators (asp’
Smith(250-300 cP). (Liquid
on all bolus trials)
Hammond · Mild aspirators (asp’ on
prepared to match available
(2001)
drinks to inpatients).
one or two bolus
consistencies)
· Between groups comparison
· Non-Aspirators (no asp’
(severe aspirators vs. nonacross trials)
aspirators)

Pitts
(2008)

·
·
·
·

Parkinson’s disease
N = 20
Safe: PAS score 1
Unsafe: PAS score 2-8

· VFSS
· 30mL liquid
· Between groups comparison
(safe vs. unsafe)

· Stroke
· VFSS (n = 91) or FEES (n =
· N = 96
5)
· Pearson correlation
Smith· Non-aspirators: PAS
Hammond
score 1-4
coefficient to determine
(2009)
associations between
· Aspirators: PAS score 5aspiration risk (PAS ≥ 5) and
8
objective cough measures

Severe aspirators (vs. non-aspirators) demonstrated:
· Lower peak inspiratory flow rate (770.60 vs. 1,120
mL/s)
· Lower peak expiratory flow rate (-875.13 vs. 1,884.14 mL/s)
· Higher expiratory rise times (0.34 vs. 0.09 sec)
· Lower cough volume acceleration (5.49 vs. 27.84
mL/s/s)

PD patients with unsafe PD swallowing demonstrated:
· Longer compression phase durations (0.36 vs. 0.16
sec)
· Higher expiratory rise times (0.41 vs. 0.21 sec)
· Lower peak expiratory flow rate (6.17 vs. 8.94 L/s)
· Lower cough volume acceleration (17.02 vs. 45.24
L/s/s)
Stroke patients who aspirated demonstrated:
· Lower inspiration phase volume (0.45 vs. 0.69 L)
· Lower inspiration peak flow (-0.82 vs. -1.44 L/s)
· Lower peak expiratory flow rate (1.98 vs. 5.62 L/s)
· Higher expiratory rise times (161.50 vs. 14.05 ms)
· Lower cough volume acceleration (23.49 vs. 136.15
L/s/s)

·
·
·
·

Parkinson’s disease
N = 58
Safe: PAS score 1
Unsafe: PAS score 2-8

· VFSS
· 30mL liquid
· Receiver operator
characteristic analysis

Discriminant ability of voluntary cough airflow
measures to detect penetration/aspiration:
· Compression phase duration: CP: 0.2 s, sensitivity:
95.8%, specificity: 64.7%, LR: 2.7, AUC: 0.83
· Expiratory phase rise time: CP: 70.8 ms, sensitivity:
70.8%, specificity: 64.7%, LR: 2.7, AUC: 0.71
· Expiratory phase peak flow: CP: 7.5 L/s, sensitivity:
87.5%, specificity: 50%, LR: 1.8, AUC: 0.69
· Cough volume acceleration: CP: 84.5 s/s, sensitivity:
54.5%, specificity: 97.1%, LR: 18.4, AUC: 0.72

·
·
·
·

Parkinson’s disease
N = 40
Safe: PAS score 1-2
Unsafe: PAS score 3-8

· VFSS
· ~5mL thin liquid; cup sip thin
liquid; two sequential sips
thin liquid; spoon-sized
pudding bolus; cookie coated
in barium
· Between groups comparison
among cough parameters and
penetrator/aspirator vs. nonP/A

On the first cough of the epoch, PD patients with safe
vs. unsafe (PAS≥4) swallowing demonstrated:
· Longer compression phase durations (0.45 vs. 0.22
s)
· Lower peak expiratory flow rates (5.51 vs. 4.19 L/s)
· Lower amount of air expired during the sequential
cough (49 vs. 42%)

Pitts
(2010)

Hegland
(2014)

Plowman
(2016)

Significant Outcomes: Summary of Results

· Amyotrophic Lateral
Sclerosis
· N = 70
· Safe: PAS score 1-2
· Unsafe: PAS score 3-8

· VFSS
· 20mL liquid
· Between group comparisons
and receiver operator
characteristic analysis.

Unsafe ALS patients demonstrated:
· Lower cough volume acceleration (33.21 vs. 103.71
L/s/s)
· Longer peak expiratory rise times (159.20 vs. 78.80
ms)
· Lower peak expiratory flow rate (2.88 vs. 5.31 L/s)
Discriminant ability of voluntary cough airflow
measures to detect penetration/aspiration:
· Cough volume acceleration: CP: 45.3s/s, sensitivity:
91.3%, specificity: 82.2%, LR: 5.1, AUC: 0.85
· Expiratory rise time: CP: 80 ms, sensitivity: 82.6%,

Abbreviations: FEES: Fiberoptic Endoscopic Evaluation of Swallowing; PAS: Penetration-Aspiration Scale;
VFSS: Videofluoroscopic Swallow Study; CP: cut point; AUC: area under the curve value; PPV: Positive
predictive value, LR: Likelihood ratios

voluntary cough airflow measures and swallowing and noted significant relationships between
expulsive rise times and aspiration status (p < 0.001) in 43 stroke patients (Smith Hammond,
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2001). Subsequently Smith-Hammond et al. (Smith Hammond, Goldstein, Horner, Ying, Gray,
Gonzalez-Rothi, & Bolser, 2009) expanded these preliminary findings in a larger cohort of 96
stroke patients who underwent cognitive testing, a CSE, voluntary cough spirometry testing, cough
sound pressure level testing (dB SPL), and an instrumental swallow evaluation (either FEES or
VFSS). Swallow safety status was objectively defined using the Penetration-Aspiration Scale
(PAS) score (Smith Hammond, Goldstein, Horner, Ying, Gray, Gonzalez-Rothi, & Bolser, 2009),
with participant groups delineated into non-aspirators (PAS > 4) vs. aspirators (PAS ≥ 5). Clinical
indications such as absent swallow initiation, difficulty with secretions, and elicitation of postprandial reflexive cough had an overall sensitivity of 53% and specificity of 83%, indicating poor
sensitivity and moderate specificity in relation to the clinical assessment measures. Acoustic cough
testing demonstrated clinical utility, with mean cough sound-pressure levels significantly lower in
aspirators compared to non-aspirators (83.7 vs. 96.4 dB SPL; p < 0.0001). There were significant
differences in several cough airflow measures between the groups. Specifically, non-aspirators
demonstrated lower inspiration phase volume (0.45 vs. 0.69 L; p < 0.05), inspiration peak flow
(-0.82 vs. -1.44 L/s; p < 0.0001), peak expiratory flow rate (1.98 vs. 5.62 L/s; p < 0.0001), higher
expiratory rise times (161.50 vs. 14.05 ms; p < 0.0001), and lower cough volume acceleration
(23.49 vs. 136.15 L/s/s; p < 0.0001). These authors concluded that, in addition to instrumental
swallowing assessment techniques, objective measures of voluntary cough spirometry may be
useful in identifying airway safety status in individuals post stroke (Smith Hammond, Goldstein,
Horner, Ying, Gray, Gonzalez-Rothi, & Bolser, 2009).
Parkinson’s disease
Pitts et al. (2008) first documented relationships between voluntary cough airflow
measures and swallowing airway safety status in 20 individuals with Parkinson’s disease (PD).
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Unsafe PD swallowers (PAS > 2) demonstrated longer compression phase durations (0.36 vs.
0.16s; p < 0.001), longer peak expiratory rise times (0.41 vs. 0.21s; p < 0.001), lower peak
expiratory flow rates (6.17 vs. 8.94 L/s; p < 0.001), and lower cough volume accelerations (17.02
vs. 45.24 L/s/s; p < 0.001).
In a larger follow-up investigation, Pitts and colleagues (Pitts, Troche, Mann, Rosenbek,
Okun, & Sapienza, 2010) evaluated the discriminant ability of voluntary cough airflow measures
for detecting unsafe swallowing in 58 individuals with PD. Results of this work indicated that the
same four cough measures reported to be different in their earlier study demonstrated good
discriminant ability to detect unsafe PD swallowers (Pitts, Troche, Mann, Rosenbek, Okun, &
Sapienza, 2010).
Hegland et al. (2014) most recently demonstrated that sequential voluntary cough is
associated with airway safety status in individuals with PD (Hegland, Okun, & Troche, 2014).
Airflow measures were recorded and objective cough spirometry measures, including percent
cough expired volume (%CEV), were obtained across two trials of sequential voluntary coughs.
Significant differences between safe (PAS < 2) vs. unsafe (PAS > 3) swallowing groups were
noted for: compression phase duration, expiratory peak flow, and percent cough expired volume
(p < 0.05). PD patients with safe swallowing demonstrated coughs with higher peak expiratory
flow rates, cough volume acceleration, and percent cough expired volume (i.e. significantly
different in the first and third expiratory effort). Further, Hegland and colleagues noted that
differences in cough-expired volumes between safe and unsafe swallow groups provided evidence
of uncoordinated sequential cough patterns in the unsafe swallow PD subjects (Hegland, Okun, &
Troche, 2014).
Amyotrophic Lateral Sclerosis
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Plowman et al. (Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016)
studied voluntary cough spirometry airflow measures and airway safety status in 70 individuals
with amyotrophic lateral sclerosis (ALS). Participants completed both voluntary cough airflow
testing and a VFSS and were grouped into safe (PAS ≤ 2) or unsafe (PAS ≥ 3) ALS swallowers.
Similar to findings in stroke and PD patient populations, significant differences were observed
across a number of measures. ALS patients with unsafe swallowing demonstrated lower cough
volume acceleration (33.21 vs. 103.71 L/s/s, p = 0.00001), longer peak expiratory rise times
(159.20 vs. 78.80 ms, p = 0.003), and lower peak expiratory flow rates (2.88 vs. 5.31 L/s, p =
0.00005). Further, these three expiratory phase measures showed a good discriminant ability to
detect the presence of penetration and/or aspiration (see Table 2.3 for full results) (Plowman,
Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016). Sensitivity and specificity were
highest for cough volume acceleration (91.3 and 82.2% respectively) and ALS patients whose
cough volume acceleration was below 45.28L/s/s were 5.12 times more likely to penetrate/aspirate.
These authors concluded that impairment in the expiratory phase of voluntary cough may be
related to degeneration of laryngeal, respiratory, and upper aerodigestive tract musculature, which
compromises the ability to build ballistic force generation needed for an effective expiration phase
(Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016). Recommendations were
made for the consideration of cough-flow testing in the clinical screening of individuals with ALS
and the use of their published cut points as references when considering airway safety risk status
(Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016).
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Table 2.3 Review of six research studies investigating the significant differences in voluntary
cough measures between unsafe (penetrators and/or aspirators) and safe (non-aspirators)
swallowers in dysphagic populations including Stroke, Parkinson’s disease, and Amyotrophic
Lateral Sclerosis.
First
Author
(Year)

Patient Population
Number (N) Studied
Swallowing Safety
Groups:
·
·
·
·

SmithHammond
(2001)

·

·

Pitts
(2008)

SmithHammond
(2009)

·
·
·
·

Swallowing Assessment
Method
and Testing Stimuli
Statistical Comparison:

Stroke
· VFSS or FEES (group n is
N = 43 Stroke; 18
not specified)
control
· 5mL, 15 mL, and
Three airway safety
unregulated cup sips of
groups:
thin liquid, Ensure Plus,
Severe aspirators (asp’
and ‘thickened liquid’
on all bolus trials)
(250-300 cP). (Liquid
Mild aspirators (asp’
prepared to match
on one or two bolus
available drinks to
consistencies)
inpatients).
Non-Aspirators (no
· Between groups
asp’ across trials)
comparison (severe
aspirators vs. nonaspirators)

Severe aspirators (vs. non-aspirators) demonstrated:
· Lower peak inspiratory flow rate (770.60 vs. 1,120
mL/s)
· Lower peak expiratory flow rate (-875.13 vs. 1,884.14 mL/s)
· Higher expiratory rise times (0.34 vs. 0.09 sec)
· Lower cough volume acceleration (5.49 vs. 27.84
mL/s/s)

· VFSS
Parkinson’s disease
· 30mL liquid
N = 20
· Between groups
Safe: PAS score 1
comparison (safe vs.
Unsafe: PAS score 2-8
unsafe)

PD patients with unsafe PD swallowing demonstrated:
· Longer compression phase durations (0.36 vs. 0.16
sec)
· Higher expiratory rise times (0.41 vs. 0.21 sec)
· Lower peak expiratory flow rate (6.17 vs. 8.94 L/s)
· Lower cough volume acceleration (17.02 vs. 45.24
L/s/s)

· Stroke
· VFSS (n = 91) or F EES (n
· N = 96
= 5)
· Non-aspirators: PAS
· Pearson correlation
score 1-4
coefficient to determine
associations between
· Aspirators: PAS score
aspiration risk (PAS ≥ 5)
5-8
and objective cough
measures

Stroke patients who aspirated demonstrated:
· Lower inspiration phase volume (0.45 vs. 0.69 L)
· Lower inspiration peak flow (-0.82 vs. -1.44 L/s)
· Lower peak expiratory flow rate (1.98 vs. 5.62 L/s)
· Higher expiratory rise times (161.50 vs. 14.05 ms)
· Lower cough volume acceleration (23.49 vs. 136.15
L/s/s)

·
·
·
·

Parkinson’s disease
· VFSS
N = 58
· 30mL liquid
Safe: PAS score 1
· Receiver operator
Unsafe: PAS score 2-8
characteristic analysis

Discriminant ability of voluntary cough airflow measures
to detect penetration/aspiration:
· Compression phase duration: CP: 0.2 s, sensitivity:
95.8%, specificity: 64.7%, LR: 2.7, AUC: 0.83
· Expiratory phase rise time: CP: 70.8 ms, sensitivity:
70.8%, specificity: 64.7%, LR: 2.7, AUC: 0.71
· Expiratory phase peak flow: CP: 7.5 L/s, sensitivity:
87.5%, specificity: 50%, LR: 1.8, AUC: 0.69
· Cough volume acceleration: CP: 84.5 s/s, sensitivity:
54.5%, specificity: 97.1%, LR: 18.4, AUC: 0.72

·
·
·
·

Parkinson’s disease
· VFSS
N = 40
· ~5mL thin liquid; cup sip
Safe: PAS score 1-2
thin liquid; two sequential
Unsafe: PAS score 3-8
sips thin liquid; spoonsized pudding bolus;
cookie coated in barium
· Between groups
comparison among cough
parameters and
penetrator/aspirator vs.
non-P/A

On the first cough of the epoch, PD patients with safe vs.
unsafe (PAS≥4) swallowing demonstrated:
· Longer compression phase durations (0.45 vs. 0.22 s)
· Lower peak expiratory flow rates (5.51 vs. 4.19 L/s)
· Lower amount of air expired during the sequential
cough (49 vs. 42%)

Pitts
(2010)

Hegland
(2014)

Significant Outcomes: Summary of Results

Abbreviations: FEES: Fiberoptic Endoscopic Evaluation of Swallowing; PAS: Penetration-Aspiration Scale;
VFSS: Videofluoroscopic Swallow Study; CP: cut point; AUC: area under the curve value; PPV: Positive predictive
value, LR: Likelihood ratios

These studies, across three different neurogenic patient populations, highlight the potential
utility of voluntary cough assessment during the clinical evaluation of swallowing. Several
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limitations exist, however, regarding the practical implementation of such testing protocols. First,
the equipment required to perform such testing is expensive and likely cost-prohibitive in most
clinical settings. Second, specialized software and training of personnel is required to analyze
cough waveforms and the analyses are labor and time intensive. Finally, this equipment is not
easily portable, posing a barrier to access in certain patient populations. A potential alternative to
the gold standard pneumotachograph airflow testing techniques utilized in the aforementioned
studies is the use of a hand-held digital, or analogue, peak cough flow meter capable of measuring
peak cough flow (L/s) and forced expiratory volume (FEV1, L) in real time without the need for
waveform analysis or cost-prohibitive equipment. Indeed, Silverman et al. (Silverman, CarnabyMann, Pitts, Davenport, Okun, & Sapienza, 2014) recognized this need and studied the
concordance of several handheld digital and analog peak cough flow devices to quantify peak
cough airflows compared to the gold-standard pneumotachograph method. Silverman et al
(Silverman, Carnaby-Mann, Pitts, Davenport, Okun, & Sapienza) indicated that both digital and
analog devices (the Mini Wright peak flow meter, and Mini Wright digital peak flow meter)
demonstrated good concordance with the gold standard method for measuring peak cough flow in
healthy males and older female PD patients. The analog peak airflow device was reported to
demonstrate a higher level of concordance for cough strength in both healthy and disease states
(Silverman, Carnaby-Mann, Pitts, Davenport, Okun, & Sapienza, 2014). It is important to note,
however, that these devices do not provide the detailed measurement parameters offered by cough
spirometry testing. Additionally, there is contraindicating evidence that documents poor agreement
between portable peak flow meter readings and the peak cough flow as measured by the gold
standard physiologic assessment (i.e., pneumotachograph) (Kulnik, Macbean, Birring, Moxham,
Rafferty, & Kalra, 2015). Further research is necessary to determine the validity of voluntary
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cough testing using such handheld devices in several patient populations and healthy controls.
An additional consideration regarding the utility of voluntary cough testing in the
evaluation of swallowing function is the fact that evaluating a volitional cough (i.e. asking a patient
to cough) does not provide direct information on the nature of a protective cough response to
aspirated material during swallowing (i.e. triggered by afferent stimuli in the airway).
Additionally, voluntary cough production is highly dependent on instruction. That is, airflow
patterns and perceived “strength” of a cough has been noted to change in a graded manner based
upon the instruction provided (Davenport, 2008). A testing method that more closely models an
airway protective cough response is the reflexive cough testing method, and will be discussed next.
Reflexive or Induced Cough Testing
Another method of testing cough is to perform reflexive cough testing to induce or elicit a
cough response and measure response profiles. Using this method, an individual inhales an
aerosolized irritant such as capsaicin, citric acid aerosols, fog, tartaric acid, acetic acid, or
hypertonic solutions (Fontana & Widdicombe, 2007) that can be delivered at different
concentrations through a nebulizer or facemask. A patient’s response profile can then be measured
and their cough threshold determined and compared to normative values. Outcomes can be as
simple as a binary measure (present / absent cough response) or airflow parameters can be
measured using the cough spirometry techniques previously discussed. In addition to measuring
the motor output of the cough response, the afferent aspect of this sensorimotor behavior can be
probed by asking the patient their perceived ‘Urge to Cough’ using a modified Borg scale across
each cough trial (Davenport, 2008). Cough output is affected by irritant type, concentration,
volume and duration of exposure, order of presentation, placebo trials, nasal afferent stimulation,
and lung volume at the start of cough initiation (Troche, Brandimore, Godoy, & Hegland, 2014).
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These variables impact cough flow rates, number of coughs produced, urge to cough (self-report),
amplitude and duration of expiratory muscle activation, and time to initiation of a cough response
(Troche, Brandimore, Godoy, & Hegland, 2014). Similar to voluntary cough testing, several
investigators have examined the potential discriminant ability of reflexive cough testing in
determining swallowing safety status, which will now be highlighted. A summary of these studies
is provided in Table 2.4.
Table 2.4 Summary of published reports investigating the discriminant ability of reflexive
cough testing to detect swallowing safety.
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Abbreviations: FEES: Fiberoptic Endoscopic Evaluation of Swallowing; NPV: Negative predictive value; OR: Odds
ratio; PAS: Penetration Aspiration Scale; PPV: Positive predictive value; SCT: Simplified Cough Test (reflexive
cough test); VFSS: Videofluoroscopic Swallow Study.
*Heterogeneous sample Sato (2012) included 141 consecutive patients; 89 individuals post stroke, 22 disuse
syndrome, 8 neuromuscular, 14 respiratory, 3 cancer, 2 cervical spine injury, 3 miscellaneous. Neuromuscular
disease included Parkinson’s disease, corticobasal degeneration, multiple systems atrophy, and spinocerebellar
degeneration. Miles (2013) included Stroke, Head and neck cancer, respiratory, progressive neurological, other
neurological, and other.
∞Binary classification based on total number of coughs produced was as follows: “responders” were defined as those
who produced at least 2 coughs on 2/3 trials for each irritant type independently (fog and capsaicin).
** Positive cough response defined as two or more consecutive coughs triggered.

Sato et al. (2012) evaluated 141 consecutively referred patients with non-specific
complaints of dysphagia. Primary medical diagnoses included stroke, neuromuscular disease,
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deconditioning, respiratory disease, cancer, cervical spinal injury, and ‘miscellaneous.’ FEES
was used to determine airway safety status, yielding 53 unsafe swallowers (aspirators) and 88
safe swallowers (no aspiration). Reflex cough testing was performed using a citric acid-saline
solution [1% weight/volume (w/v)] to induce a reflexive cough with time from citric-acid
administration to elicitation of the first cough the primary metric of interest. Results indicated
that time to first cough demonstrated excellent discriminant ability for identifying silent
aspirators in this cohort. Specifically, a value of 30 seconds post-irritant administration to the
first cough demonstrated a sensitivity and specificity for detection of silent aspiration of 92% and
94%, respectively. When including all aspirators, however, a cutoff of 60 seconds for cough
reaction time yielded a sensitivity and specificity for detection of aspiration at 81% and 65%.
These results suggest that subtle differences in cough reaction time affects the accuracy of
detecting silent aspiration.
Miles at al. (2013) examined the utility of reflexive cough testing for identification of silent
aspiration in 181 consecutively referred inpatients with diagnoses including stroke, head and neck
cancer, ‘respiratory disease,’ progressive neurologic disease, and ‘other.’ All individuals were
evaluated with reflexive cough testing and an instrumental swallowing evaluation (either FEES or
VFSS). Swallowing safety status was determined by a blinded SLP who rated either the FEES or
VFSS using the PAS scale and patients were grouped by: no aspiration, aspiration with cough (not
specified if it was an effective cough), trace silent aspiration, and silent aspiration
Cough thresholds were evaluated using randomly administered citric acid solutions (0.4
mol/L, 0.6 mol/L, 0.8 mol/L, and placebo) via facemask nebulizer on a continuous flow. The
primary outcome measure was presence or absence of cough following each 15-second interval.
The trial was considered a “positive” response and if the patient coughed two or more times at a
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given concentration. Additionally, researchers perceptually rated subjective cough response
strength (weak or strong). The concentration of 0.6 mol/L was shown to have the highest level of
accuracy for discriminating between safe and unsafe swallowers on the VFSS (sensitivity of 71%,
specificity of 60%). However, these values are considered below ideal for a good screening tool.
More recently, Hegland et al. (2016) investigated cough response profiles to varied irritant
types in both healthy controls and individuals with PD. Patients underwent VFSS and were
categorized into safe (non-aspirators, PAS ≤ 4) vs. unsafe (aspirators, PAS ≥ 5) swallowing groups.
Irritant stimuli included diluted capsaicin (200μM dissolved in vehicle solution of 80%
physiologic saline and 20% ethanol) and aerosolized water (fog). Both irritants were delivered
through a nebulizer (Omron Micro-Air NE U22 V, Tokyo, Japan) for 60 seconds and the mean
number of coughs produced within a 30 second time-frame and categorical ‘responders’ and ‘nonresponder’ data was collected. For binary responder/non-responder outcomes, there were
differences in response to irritant type with regards to the sensitivity and specificity for detecting
laryngeal penetration and/or aspiration. Specifically, capsaicin yielded a sensitivity of 44.4% and
specificity of 100% and fog a sensitivity of 77.8% and specificity of 90.9%. Additionally, there
were significant differences in the number of coughs produced between safe and unsafe
swallowers, with unsafe swallowers producing fewer coughs to both fog and capsaicin.
Hegland and colleagues reported poor sensitivity (20%) but good specificity (95.9%) for
detecting unsafe swallowing with reflexive cough testing (using capsaicin) in PD (Hegland,
Troche, Brandimore, Okun, & Davenport, 2016) and concluded that the high false negative (not
detecting an impairment) may indicate that the single inhalation may not be the correct
methodology to implement to rule out aspiration in this population. The authors also reported that
a difference in response to fog vs. capsaicin suggests possible differences in neural control of
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cough regulation.
Kallesen et al. (Kallesen, Psirides, & Huckabee, 2016) investigated the clinical utility of
reflexive cough testing for assessment of swallowing impairment in 106 recently extubated
intensive care unit patients (Kallesen, Psirides, & Huckabee, 2016). Patients underwent FEES
evaluation and reflexive cough testing with concentrations of 0.4, 0.6, and 0.8 mL/L nebulized
citric acid mixed with 0.9% sodium within 24 hours of extubation. The PAS was used to
differentiate penetrators (PAS < 5) vs. aspirators (PAS ≥ 6), yielding 13 aspirators, 9 of which
were identified as silent aspirators (69%). Concentrations of 0.4, 0.6, and 0.8 mL/L demonstrated
sensitivity values of 100%, 100%, and 88% and a specificity of 42%, 49%, and 58% for detecting
aspiration, respectively. Kallesen and colleagues concluded that reflex cough testing overidentified aspiration in this patient population.
Multiple variables can be manipulated when performing reflexive cough testing and thus,
may result in drastically different patient responses. These studies highlight the potential utility of
reflexive cough evaluation for the assessment of aspiration status and also provide complimentary
literature to the voluntary cough testing. Cough reflex testing methodology may be more practical
as part of a screening assessment as the methodology is inexpensive, quick to administer, and
objective outcomes relatively simple to interpret. However, the lack of consensus for testing
protocols and scarce data in multiple patient populations highlight an important gap in the
literature. This leads to the inability to provide cohesive practice recommendations in regards to
the optimal irritant type and strength of solution, length of delivery, and outcome measures.
Although these articles provide an excellent foundation, more research is warranted to provide
guidelines to practicing clinicians.
Limitations and Future Directions
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Although an emerging and promising dataset supports the use of cough testing in the
clinical evaluation of swallowing, current data is limited and restricted to only a few patient
populations with a critical need for more data to validate these promising findings in other patient
populations. Practical limitations of objective voluntary cough testing procedures necessitate the
need for further studies to examine the discriminant ability of simple and inexpensive cough testing
using handheld peak-flow meters, similar to the work of Silverman and colleagues (Silverman,
Carnaby-Mann, Pitts, Davenport, Okun, & Sapienza, 2014). Reflexive cough testing represents a
relatively simple, inexpensive and relatively quick method of testing that is currently being utilized
clinically by Dr. Karen Hegland in a busy clinic for individuals with Parkinson’s disease, with
binary cough threshold testing and urge to cough screens performed routinely at every patient visit
(Hegland, personal communications).
Conclusions
This narrative review highlights the shared neural and anatomical substrates mediating
cough and swallowing, as well as the co-occurring presence of dystussia and dysphagia.
Additionally, the role of cough in defending the airway and rationale for providing a physiologic
index of airway defense in patients at risk for dysphagia has been delineated. A small but growing
body of literature supports the inclusion of cough testing in the CSE to provide an index of overall
function and capacity of airway defense mechanisms to aide in clinical and diagnostic decisionmaking and assessment of potential risk of impairments in swallowing safety. Clearly more data
are needed to validate these findings, in addition to using practical, inexpensive and efficient
methods that can be easily implemented in busy clinical settings to provide valid and reliable
results across practice settings.
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CHAPTER THREE
CURRENT PRACTICE PATTERNS
Introduction
Dysphagia is a symptom of underlying disease and unfortunately, associated with a variety
of medical diagnoses. Dysphagia adversely impacts health status, quality-of-life (QOL), and
creates financial burden for patients and their caregivers (Cichero, 2012; Leow, Huckabee,
Anderson, & Beckert, 2010; Maclean, Cotton, & Perry, 2009). When evaluating the swallowing
process, it is critical to incorporate assessment of airway safety status, bolus efficiency, and airway
protective ability (i.e., cough). Impairments in these domains often lead to pulmonary sequela, and
undernourishment (Guest, Panca, Baeyens, De Man, Ljungqvist, Pichard, Wait, & Wilson, 2011).
Pulmonary infection also termed, aspiration pneumonia, has been identified as the leading cause
of death Parkinson’s disease (PD) and the elderly (Fernandez & Lapane, 2002; Gorell, Johnson, &
Rybicki, 1994; Hely, Reid, Adena, Halliday, & Morris, 2008; Marik & Kaplan, 2003; Shill &
Stacy, 1998). Further, malnutrition has been associated with oropharyngeal dysphagia in the
geriatric population, (Cabre, Serra-Prat, Force, Almirall, Palomera, & Clave, 2014; Chapman,
2006; Namasivayam-Macdonald, Morrison, Steele, & Keller, 2017) and increases the risk of death
in individuals with amyotrophic lateral sclerosis (ALS) (Chio, Logroscino, Hardiman, Swingler,
Mitchell, Beghi, Traynor, & Eurals, 2009; Serra-Prat, Palomera, Gomez, Sar-Shalom, Saiz,
Montoya, Navajas, Palomera, & Clave, 2012). Timely identification of swallowing impairment
and reduced ability to protect the airway is vital to ensure implementation of management
strategies to optimize oral intake and maintain pulmonary health and patient QOL.
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Physicians, nurses, and speech-language pathologists (SLP) who hold a certificate of
clinical competency (CCC-SLP) perform clinical swallow assessments (CSE) across a variety of
health care settings hospitals and skilled nursing facilities (Association, 2000; Logemann, 1998).
Regardless of the practitioner, an individual may only have five to fifteen minutes to determine a
patient’s swallow safety status. The accuracy of clinical swallow evaluation techniques and
assessment capabilities of airway protective behaviors vary widely (Daniels, Anderson, & Willson,
2012; Leder, Suiter, Murray, & Rademaker, 2013; Mathers-Schmidt & Kurlinski, 2003). CSE
components may include: review of case history, cranial nerve assessment, clinical feeding trials
of various bolus consistencies, and a voice quality assessment (McCullough, Wert, Rosenbek
2001, McCullough, Rosenbek, Wertz, McCoy, Mann, McCullough, 2005, Daniels, Anderson,
Willson, 2012). However, a recent study has shown that SLPs prioritize clinical skills and
reasoning above following an outlined checklist assessment method such as item-based protocols
(Mcallister, Kruger, Doeltgen, & Tyler-Boltrek, 2016).
Of late, there is increasing evidence indicating the usefulness of gold standard voluntary
cough using spirometry to determine airway safety status (Pitts, Bolser, Rosenbek, Troche, &
Sapienza, 2008; Pitts, Troche, Mann, Rosenbek, Okun, & Sapienza, 2010; Plowman, Watts,
Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016; Smith Hammond, Goldstein, Horner, Ying,
Gray, Gonzalez-Rothi, & Bolser, 2009; Smith Hammond, 2001; Troche, Okun, Rosenbek,
Musson, Fernandez, Rodriguez, Romrell, Pitts, Wheeler-Hegland, & Sapienza, 2010). However,
instrumental voluntary cough testing methods remain outside of current CSE published guidelines.
With the addition of quality literature over the past decade regarding relationships between cough
and swallow, it remains is unclear if subjective assessment of voluntary cough sound is widely
used in clinical practice, and/or what aspects of cough are being considered as clinically useful.
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The lack of insight into current practice patterns of voluntary cough assessment limits the
usefulness of research on optimization of cough techniques that are easily implemented in the
clinical settings. Consequently, the aim of the current investigation is to define current practices
for subjective voluntary cough assessment during the CSE. Based on limited clinical practice
guidelines for cough testing and limited inclusion of cough testing methods included in CSE’s, it
is hypothesized that across a variety of medical settings that subjective assessment of cough sound
is not routinely implemented despite years of training or clinical experience.
Methods
Participants
SLPs and other medical professionals who currently assess swallowing were targeted to
complete an online survey via forum post on two professional organization sites: American Speech
Language Hearing Association (ASHA) special interest group 13 (swallowing and swallowing
disorders) and Dysphagia Café. A total of 781 individuals responded to the survey. This study
received approval by the University of South Florida Institutional Review Board (#00017474) (see
Appendix B) and all participants provided consent via an online questionnaire prior to the initiation
of the survey.
Materials and Procedures
Qualtrics online survey software was used to construct, disseminate, and store acquired
survey data (Qualtrics; Provo, UT). The pilot survey included 22 questions divided into two
sections: 1) demographic information; and 2) bedside swallow evaluation practices with specific
reference to cough testing. Questions regarding perceptual cough assessments allowed for free text
answers for trend analysis. In addition, survey construction was designed to reduce participant
bias. Field-testing of the pilot survey included review of each item for relevance, mutually
60

exclusivity, and clinical significance. There were a total of 18 remaining questions following fieldtesting (please see Appendix C to view the final constructed survey questions).
The electronic survey format, Qualtrics, allowed for the use of “skip logic.” Certain
questions were revealed to the participant based on response to a prior question. For example, if
the participant answered “no” to the question, “Are you a Speech Language Pathologist (SLP)?”
the question, “What is your SLP certification level?” was skipped. Mandatory responses (14 in
total) were deemed as responses that must be completed despite skip logic. These are denoted in
Appendix C.
Participants had access to the survey for a total of three months. A two-tier elimination
process was utilized to evaluate for completed and appropriate responses. First, given that the
survey was related to CSE practice patterns, participants who responded “no” to “do you conduct
clinical swallow examinations?” or left the response blank were excluded. This exclusion resulted
in resulted in 722 valid responses. Lastly, mandatory responses (items displayed regardless of skip
logic) were tabulated; participants who completed <85% of mandatory responses were excluded,
this resulted a total of 605 survey responses used for analysis.
Statistical Analysis
Survey responses were analyzed using descriptive and associative methods. A Chi-square test
statistic was used to determine if there was a significant difference in voluntary cough assessment
patterns between certification level and years of experience. This was chosen because the nominal
data was derived from a random sample, the sample groups were independent of one another and
observations within the sample groups were independent of one another (i.e., respondents were in
one category or another). Binary and categorical data were summarized as frequencies. Open
question responses were analyzed based on thematic content and grouped according to theme. Data
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is presented as mean ± standard deviation (SD), and significance was set at p < 0.05.

Results
Participant Demographics
Following the two-tier elimination process to include appropriate and complete responses,
605 out of 781 (77%) survey responses were analyzed for this study, representing 48 states and 1
United States territory represented (see Figure 3.1). Of the 605 participants, 505 were from the
United States of America, 24 were from Canada, and 76 were from outside of North America.
Table 3.1 contains full respondent demographics. The total mean time to complete the survey was
11.7 ± 59 minutes.

1
6
40
Number of respondents by state

Figure 3.1 Color illustrative map of the United States of America representing U.S. participants
by state. The darker shaded colors indicate greater number of respondents.
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Distribution of respondents
Table 3.1 Demographic characteristics of survey respondents (N = 605).
Variable
Speech Pathologist
Yes
No
Education
Masters
Doctorate
Student
No response
Advanced Certification
Board registered swallowing
specialist (BRS-S)
Experience in medical practice (years)
<1
1-2
3-5
6 - 10
11 - 20
20 +
No response
Country of Practice
USA
Canada
Other
Work Environment**
Hospital
Skilled nursing facility
Outpatient rehabilitation
Multiple practice locations
Voice and swallow center
Private Practice
Home Health
Graduate training clinic
Other

(n)

%

597
8

98.7
1.3

468
41
82
14

77.3
6.8
13.6
2.3

18

2.9

65
94
139
122
92
84
9

11.0
15.5
23.0
20.1
15.2
13.8
1.48

505
24
76

83.5
4.0
12.5

213
204
70
49
18
14
14
12
11

35.2
34.7
11.6
8.1
3.0
2.3
2.3
2.0
1.8

*Final survey responses were selected using a 2-tier validation process; 1) participants
complete CSEs and 2) answered 85% or greater of the mandatory questions (i.e., not
skip logic) and conduct clinical swallowing evaluations at their setting.
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Inclusion of Voluntary Cough Assessment
Eighty-seven percent (529 of 605) of respondents reported they do assess voluntary cough
during a CSE. Two participants (< 0.5%) did not respond, however they did note specific qualities
that they look for in cough in response to a later question. See Table 3.2 for full detail of voluntary
cough assessment by workplace, years of experience, and certification status.
Table 3.2 Use of voluntary cough assessment by years of experience, practice setting, and
level of certification (n = 603).
Variable
Experience (Years)
<1
1-2
3-5
6 - 10
11 - 20
20 +
No response
Total
Practice Setting
Home Health
Hospital
Multiple Locations
Other
Outpatient
Rehabilitation
Private Practice
Skilled Nursing
Graduate Clinic
Voice/Swallow Center
No Response
Total
Certification Group
Student/Training
Masters
Advanced Training
No Response
Total

Voluntary cough
Assessment (n)
Yes
No
52
81
125
106
80
76
9

13
13
13
16
11
8
-

529

74

12
183
46
8
62

2
29
3
3
8

13
178
10
17
529

1
25
2
1
74

67
411
37
14
529

15
55
4
74

* Of the 605 participants who responded to years of experience, 2 did not rate whether or not
they assess voluntary cough. Description of working environment as follows: Hospital
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includes individuals identified as working in a hospital setting including inpatient
rehabilitation, multiple practice locations include individuals who identified working in
multiple settings (i.e., hospital and skilled nursing facility). “Other” category included varied
community based facilities for adults or medically fragile children.
Interaction between clinical experience and certification level
No significant difference was found between the years of clinical experience (ordinal rank
groups) and use of voluntary cough (X2 (2) = 5.893, p = 0.43). Level of certification was
categorized into three groups: 1) training status including SLP-assistant; student clinician
(currently in a master’s program); or clinical fellow (has obtained a master’s degree but has not
received professional certification), 2) professional level (CCC-SLP) and 3) advanced training
(BRS-S or Ph.D.). There was no significant difference between certification level and use of
voluntary cough (X2 (5) = 2.99, p = 0.22). Figure 3.2 depicts ranked frequencies for years of
experience.

Figure 3.2 Bar graph representing distribution of respondents who reported assessing
voluntary cough during the clinical swallow grouped by years of experience.
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Abnormal voluntary cough
For the open format question, “What aspects of voluntary cough do you listen for to
indicate abnormality (e.g., strength)?” 523 responses were analyzed (523/605) responded to this
question). The number of descriptive terminologies used to describe disordered cough varied
greatly. The minimum number of descriptors = 1, maximum = 7, the average number of descriptor
to describe disordered cough was 2.7 ± 1.2. Trends in the use of the terms strength, loudness,
effectiveness, and productive to describe aberrant voluntary cough sounds were analyzed. The
most prevalent individual term was “strength.” This term was used by 458/523 respondents
(87.5%) to evaluate voluntary cough for the purpose of assessing airway protection. When
combing this term with “weak,” the number increased to 470/523 (89.9%) respondents. The second
most commonly used term was “productive” with 91/523 (17.4%) respondents using this to assess
ability to protect the airway. The third most commonly used term was “volume/loudness,” used by
34/523 (6.5%) and respondents. The fourth most commonly used term was “effective/ineffective,”
used by 19/523 (3.6%) respondents. Respondents also listed a variety of terms outside of the
aforementioned categories including: “acoustics,” “respiratory strength,” “pharyngeal residue,”
and “strength of exhalation.”
Clinical Swallowing Assessment Pattern
Participants reported having knowledge of one or all of the following clinical swallow
protocols: Gugging Swallowing Screen (Trapl, Enderle, Nowotny, Teuschl, Matz, Dachenhausen,
& Brainin, 2007); Modified Mann Assessment of Swallowing Ability (MASA) (Mann, 2002); The
Toronto Bedside Swallowing Screening Test (TOR-BSST) (Martino, Silver, Teasell, Bayley,
Nicholson, Streiner, & Diamant, 2009); and Yale 3 ounce water swallow test (Suiter, Sloggy, &
Leder, 2014). Fifty-three percent of individuals use one of the validated clinical swallowing
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protocols listed above. The option for open typed responses was provided in order facilitate insight
as to why a validated protocol was not followed during a clinical swallowing evaluation.
Responses were grouped thematically. The following reasons were provided for not following a
validated CSE protocol: 1) “not part of policy at the hospital”; 2) “not a common practice in the
particular country”; 3) “lack of training/education/access/familiarity”; 4) “learned a specific way
of informal swallow clinical protocol”; 5) “a specific non-standardized protocol is the standard
practice at the place of employment”; 6) “the evidence based practice for the protocol is not
proven”; and/or 7) “the assessments are not personalized”.
The most common assessment components that were reportedly used during a CSE
included: 1) cranial nerve assessments; 2) oral feeding trials; 3) medical chart review; and 4)
cognition/orientation testing.
Discussion
This is the first study to demonstrate that a majority of clinicians are using voluntary cough
assessment during their CSE examinations, regardless of the clinician’s level of experience or
relevant certification. While one may view this as positive trend in the SLP field; discouragingly,
a large percentage of clinicians are still not using standardized/validated CSE protocols which use
similar terminology such as “weak and strong” to denote cough impairment. Given, this lack of
standardization, there also remains a discrepancy in the language/terminology used by clinicians
to perceptually describe aberrant cough.
According to survey responders, terms related to cough “strength” are most commonly
used to define abnormality. However, rating a parameter such as strength with a binary outcome
(weak or strong) has been found to show poor ability to detect abnormality. Smith-Hammond and
colleagues (2001) demonstrated that CSE examinations of cough using terms of strength and
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quality had very low sensitivity (42 and 26 respectively). The authors further noted that almost
40% of patients who might have benefited from swallow therapy would not have been identified
based on these cough metrics. Lack of agreement on descriptive terms of cough within speech
language pathology practice and related fields studying cough may contribute to these findings as
there is a lack of consistency and understanding of perceptual cough metrics to apply to our clinical
populations. Objective cough rating using a scale indices or physiologic measurement of cough
may provide a platform for a more cohesive and systematic measurement of cough impairment in
the clinical setting.
Our data demonstrate that that the majority of survey participants (87%) are attending to the
cough process as they indicated that they do assess voluntary cough during a clinical swallowing
evaluation. When examining literature from our rehabilitation colleagues in physical and
occupational therapies, we see that “strength” can measurable within an interval rating scale (Price,
2012). Physiologically, a person’s strength can be measured by force against and object.
Objectively, strength also is a measurable phenomenon. Therefore, clinically, we may be using an
incorrect method of measurement by categorically defining perceptual cough features into “weak”
or “strong”.
A promising alternative may be the use of a peak cough flow meter to evaluate cough. For
example, Silverman et al., (2014) investigated cough measurement devices in healthy controls and
persons with PD. Thirty-five healthy controls and thirty-five participants with PD were recruited;
all participants were instructed to cough into three types of cough measurement devises: 1) an
analog peak flow meter; 2) digital peak flow meter; and 3) a pneumotacograph (gold standard
cough measurement). The participants were asked to produce three types of cough including a
“weak, moderate, and strong” cough. Authors reported that average peak cough flow outcomes
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were significantly different for both analog and digital peak flow meters and the pneumotacograph
for the presence of disease (PD) and between genders; in addition, all of the devices produced
similar normative outcome values (Silverman et al., 2014). Conversely, a study investigating the
accuracy of portable devices measuring peak cough flow indicated poor agreement between gold
standard pneumotactograph recordings and portable peak cough flow meters (Kulnik, MacBean,
Birring, Moxham, Rafferty, Kalra, 2015). Those authors highlighted the potential for inaccuracy
when using this methodology to assess peak cough flow as authors reported poor agreement
between the gold standard of airflow measurement and portable cough airflow devises (Kulnik,
S.T., MacBean, V., Birring, S.S., Moxham, J., Rafferty, G.F, Kalra, L, 2015). As within clinical
voice practice, clinicians are listening to voluntary cough and perceptually evaluating its
characteristics. Given the current discrepancy in the use of objective means of cough assessment
such as the peak flow meter and in the use of perceptual evaluation of cough, there is a need to
investigate these properties in both healthy controls and a variety of patient populations.
In many fields, agreement on, and consistent use of terminology is lacking and often there
are overlapping and poorly defined terms to describe abnormality. Within the field of speechlanguage pathology, we can look within the voice literature and see that many terms have been
used to describe voice quality based on an auditory-perceptual assessment of voice (Hirano, 1981).
Even among expert listeners, there can be discrepancies in reliability of voice ratings (Kreiman,
1996). Though it should be noted that inter- and intra-rater reliability can be very high if the
measurement methods are suitable for perceptual measurements (Shrivastav et al., 2005; Patel et
al., 2010). Reliability is especially an issue for rating scale methods, which in clinical evaluations,
typically involves a single judge and single trial listening.
The auditory-perceptual evaluation most common in current clinical practice is the
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Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) (Kempster, 2009) that relies on a
series of rating scales and other perceptual judgments. This method is similar to the grade,
roughness, breathiness, asthenia, and strain (GRABAS) scale described by (Hirano, 1981). Under
controlled laboratory conditions with expert judges, the inter- and intra-rater reliability of such
measures can be quite high (Nemr, Simoes-Zenari, Cordeiro, Tsuji, Ogawa, Ubrig, & Menezes,
2012) though other investigations have not shown such high reliability within a clinical setting
(Kreiman, 1993). The voice quality literature has created a path to assess vocal quality using
subjective perceptual rating scales as well as objective acoustic measures to inform the listener of
abnormality, even though the most widely used measures (e.g., CAPE-V) are still considered
inadequate by many professionals. Klein and colleagues (2000) examined the relationship between
objective and subjective measures of voice quality and this contribution in the description of voice
using a multichannel input for simultaneous assessment of acoustic and physiologic parameters.
The authors concluded that the subjective voice ratings indeed provided useful information
regarding the voice that the objective data alone did not convey. In the case of cough, we need to
pick terminology, clearly define this terminology, and understand what it means physiologically.
Limitations and Future Directions
There are several limitations of this study associated with the phrasing of specific questions
and those limitations make interpretation of some of the results less clear than originally planned.
For example, in the question “What aspects of cough do you listen to when assessing voluntary
cough?” the term “strength” was listed as an example of a voluntary cough feature. This potentially
biased the responders to include strength or terms related to strength in their responses and may
have led to over estimation of the use of such terms relative to terms that were not provided as
examples. Similarly, in the question “Do you assess voluntary cough (e.g., ask the patient to
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perform a cough)?” the inclusion of the example in the parenthetical clause may have biased
participants to include responses such as “perform a cough” leading to overestimation of such
responses relative to other objectives measures such as objective peak cough flow meters to test
voluntary cough function or nebulizers to assess reflexive cough function. Future work focusing
on survey analysis of the variety of clinical cough testing methodologies that are currently being
used and also clinicians feeling towards to use of new cough testing methodologies may help shape
future research aims.
Conclusion
The aim of the investigation was to define current practices for subjective voluntary cough
assessment during the CSE. It was hypothesized that across a variety of medical settings, that
subjective assessment of voluntary cough sound is not routinely implemented despite years of
training or clinical experience. The results of this study did not support that hypothesis as 89% of
survey respondents replied that they do assess voluntary cough (e.g. ask the patient to perform a
cough) during the CSE, and the use of voluntary cough testing did not differ between years of
clinical experience or certification type (i.e., advanced clinical training).
Cough evaluation within the clinical setting is gaining attention. Researchers are reporting
the utility of hand held meters to evaluate cough function in select patient populations (Silverman
et al., 2014), there are reports of perceptual variants of cough and how this relates to airflow
measures (Laciuga et al., 2016), and several authors have published data on the use of cough
airflow flow testing using a pneumotacograph to determine airway safety status. The current
survey completed by 605 participants’ shows that a majority of survey respondents across practice
settings, levels of experience, and certification are clinically assessing voluntary cough function
as part of their practice. With a growing body of basic and clinical literature demonstrating
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relationships between swallowing the airway protective behavior of cough, there is an urgent need
for standardization of cough assessment protocols and understanding terminology used to describe
aberrant cough.
Expert clinicians and scientists agree that cough is a behavior that is essential to one’s
health and wellbeing especially those who are at risk for penetration or aspiration events.
Standardization of cough assessment and common language used to describe aberrant cough may
help improve dystussia evaluation as well as direct future research aims.
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CHAPTER FOUR
PERCEPTUAL AND CLINICAL INDICES OF COUGH ASSESSMENT
Introduction
Voluntary cough measures are predictive of airway safety status during swallowing in
several patient populations including stroke (Smith Hammond C.A. , 2001; Smith Hammond,
Goldstein, Horner, Ying, Gray, Gonzalez-Rothi, & Bolser, 2009), Parkinson’s disease (PD) (Pitts,
Bolser, Rosenbek, Troche, & Sapienza, 2008; Pitts, Troche, Mann, Rosenbek, Okun, & Sapienza,
2010) and Amyotrophic Lateral Sclerosis (ALS) (Plowman, Watts, Robison, Tabor, Dion,
Gaziano, Vu, & Gooch, 2016). Voluntary cough testing methodology has varied across these
studies; however, all have utilized cough airflow testing (the current gold-standard cough
evaluation method). This methodology requires costly equipment and the analysis is labor
intensive, time consuming, and requires intensive training to perform expert evaluation of the
cough airflow waveforms. The modified barium swallow study (MBS) (the current gold-standard
swallowing evaluation method) affords visualization of airway protection safety status in real time
(Logemann, 1984). The Penetration Aspiration Scale (PAS) (Rosenbek, Robbins, Roecker, Coyle,
& Wood, 1996) is an 8-point rating scale used to quantify and categorize level of airway protection
based off of results from the MBS. A rating of 1 indicates that nothing has entered the laryngeal
vestibule and a rating of 8 indicates that swallowed material has gone below the level of the true
vocal folds and a cough response was not elicited. The PAS scale does contain information
regarding a patient’s ability to protect the airway during a swallowing task (i.e., the attempt to
“eject” the material or cough was successful or not) and therefore is efficient in understanding if a
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cough is effective or not. Unfortunately, the MBS may be costly and not readily available to all
clinicians such as those in skilled nursing facilities, home-health practitioners, or those who
provide clinical assessment via teleheath. Many clinicians utilize swallowing screening and
clinical swallowing evaluations to determine both airway safety status and assess a patient’s ability
to effectively protect the airway.
Although there are data to support the relationship between cough and swallowing, not all
available clinical swallowing assessment protocols contain a cough-testing component (Watts,
Tabor, & Plowman, 2016). Cough effectiveness is a term used to describe cough in terms of the
ability of the force of that cough to expel material from the airway. Current clinical evaluation of
cough is focused on cough frequency, peak expiratory airflow rate collected via a hand-held peak
flow meter, and subjective ratings of cough “effectiveness” in a binary manner (i.e., weak or
strong). To this point, little is known regarding the reliability or validity of clinician perceptions
of voluntary cough effectiveness during the clinical swallow evaluation (Laciuga, Brandimore,
Troche, & Hegland, 2016).
There is a paucity of data on the ways in which audible perceptual features of dystussia
(disordered cough) may differ from audible features of normal cough. Additionally, there is limited
knowledge on whether perceptual parameters of cough can inform clinicians of decreased airway
protection during swallowing, or if perceptual measures of cough are a reliable means to judge
such differences in disordered vs. functional cough. There is currently no standardized tool to
assess subjective ratings of cough impairment by healthcare professionals. There remains a great
clinical need for a cost-effective, readily available, low-tech, sensitive and specific clinical tools
to evaluate voluntary cough function. A visual analog scale (VAS) is often used to characterize
the intensity of a biological function across a simple numeric continuum (Gould et al., 2001).
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However, there is some debate throughout the literature as to whether the use of a VAS is credible
measure of certain functions (Price, Staud, & Robinson, 2012). The VAS, in the context of
quantifying the perception of pain, has been reported to demonstrate ratio-scale properties and be
sensitive to small changes in the perception of pain (Myles & Urquhart, 2005; Price, McGrath,
Rafii, & Buckingham, 1983; Price, Bush, Long, Harkins, 1994; Price & Harkins, 1987). The goals
of this study were to determine if there were differences between airway safety groups in
individuals with ALS for in perceptual measures of cough strength, loudness, and effectiveness as
measured by a VAS, and for the presence/absence of aberrant cough features. We hypothesized
that measures of cough strength, loudness, and effectiveness would be reduced in individuals with
unsafe swallowing relative to those with safe swallowing. Further, we hypothesized that
individuals with unsafe swallowing would demonstrate one or more identifiable aberrant cough
features.
Methods
Participants
Retrospective data were collected from participants who were previously enrolled in a pilot
study and a grant-funded (R21) research study run by principle investigator Dr. Emily K.
Plowman. Patients were enrolled in a treatment study assessing the effects of expiratory muscle
strength training (EMST) on swallow and respiratory function in individuals with ALS. Study data
was collected from baseline study assessment prior to participation in respiratory training.
Participants included 44 individuals with a diagnosis of probable/definite Amyotrophic Lateral
Sclerosis (ALS) in accordance with the Revised El-Escorial Criteria (Brooks Br, 2000). According
to the study protocol designed by Dr. Plowman, all patients were screened with specific inclusion
and exclusion criteria including: 1) diagnosis of probable or definite ALS; 2) Amyotrophic Lateral
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Sclerosis Rating Scale Revised score (ALSFRS-R) (Cedarbaum, 1999) greater than 32; 3) reduced
maximum expiratory pressure compared to published normative data for gender and age (Wilson,
1984 ); 4) forced vital capacity greater than 65%; 5) cognition within normal limits as determined
by > 24 points on the Mini Mental Status Exam (Folstein, 1975); 6) no reported allergies to barium;
7) no current tracheotomy or mechanical ventilation; 8) absence of diaphragmatic pacer; and 9) no
significant concurrent respiratory disease (e.g., COPD) (Plowman, Watts, Tabor, Robison,
Gaziano, Domer, Richter, Vu T, Gooch C, 2016)
Equipment
Two testing procedures were included for analysis: 1) videofluoroscopic evaluation of
swallowing and 2) standardized voluntary cough spirometry testing. For the videofluoroscopic
swallow diagnostic study, a Phillips BV Endura fluoroscopic C-arm unit (GE OEC 8800 Digital
Mobile C-Arm system type 718074) was used to acquire the radiographic images at 30 frames per
second. Cough spirometry testing was recorded on each patient using the following methodology.
An oral pneumotachograph (MLT 1000, ADInstruments, Inc; Colorado Springs, CO) was
connected to a spirometer filter (MQ 304 Spirometer Filter, Vacumed; Ventura, CA) which
recorded airflow measures via a transducer (Powerlab (8/35, ADInstruments, Inc Vacumed;
Ventura, CA) during voluntary cough production. The pneumotachograph, fitted with a sanitary
filter, was held in place by the examiner.
Testing Protocols
1) Swallow function: Patients were evaluated using a videofluoroscopic evaluation.
Videofluoroscopy is considered the “gold standard” to assess airway compromise across multiple
patient populations. Participants were seated in an upright position and both lateral and anterior
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images were obtained during the consumption of the following barium contrast boluses via
syringe: thin liquid contrast in volumes of, 1 cc, 5 cc, and 20 cc, and 5 cc of barium paste. The 20cc thin liquid trial was utilized for evaluation of airway compromise. If the patient was unable to
swallow 20 cc of the liquid contrast, the largest bolus challenge that the patient completed was
assessed. A blinded rater evaluated the level of airway compromise live and then a second blinded
rater provided reliability using the recorded video. Airway compromise was assessed using the
standardized PAS. The PAS is an 8-point scale that assesses penetration and aspiration where 1
equals no penetration or aspiration and 8 equals aspiration without a cough response (i.e., silent
aspiration). Using the PAS scale, participants where stratified into one of two swallowing safety
groups. A PAS score of 1 or 2 was classified as “safe” swallowing and a PAS score of 3
(penetration above the level of the folds with residue) to 8 was classified as “unsafe” swallowing.
2) Cough function: Patients were seated upright in a chair or wheelchair with their feet on
the floor and their arms placed on the armrests. A respiratory filter in line with a
pneumotachograph was placed in the participant’s mouth. He or she was instructed to breathe
normally for at least three tidal breaths to acclimate to the filter. According the protocol outlined
in the EMST study designed by Dr. Plowman, they were then instructed to take a deep breath and,
“cough hard like there is something stuck in your throat”. The patient completed this activity three
times. Collection of this airflow data was also audio-recorded using a Sony HD HandyCam video
recorder positioned directly in line with the pneumotachograph. This audio recording provided a
means to re-assess subjective ratings of cough effectiveness, loudness, and volume after primary
data collection.
All data was video and audio recorded. Two raters assessed perceptual cough features using
audiovisual recordings after the cough airflow data was collected. Raters evaluated perceived
77

cough strength, loudness, and effectiveness using a 100-mm, visual-analog scale (VAS) (see
Figure 4.1). More specifically, the perceived quality (weak, moderate, and strong) for cough
strength, loudness, and effectiveness were judged by marking a horizontal tic mark on a 100-mm
vertical VAS. The total possible rating for each perceptual measure was out of a 100 with 0 being
a poor rating, and 100 being a (perceptually) excellent rating. Scores for each measure were
derived by using a ruler to measure distance (in millimeters) from the “0” end point on the line to
where the horizontal tic marks were made. Additionally, raters determined the presence or absence
of binary cough quality ratings (huffing, voicing, wet, inspiratory stridor) based on operational
definitions (see Table 4.1).
Rater 1 reviewed all 44-recorded assessments and made judgments of cough strength,
loudness, and effectiveness as well as determined the presence/absence of aberrant cough features.
Using a random number generator, 20% of the 44 auditory cough epochs sampled (9) were
randomly selected to be re-analyzed by a second blinded rater. Rater 2 utilized the recorded
audio/video files to assess all perceptual parameters at a time point after data collection.

Table 4.1 Definitions of aberrant cough signs; perceptually judged to be
present/absent by a blinded rater.
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Figure 4.1 Three vertically positioned 100-mm lines were used as a VAS for perceptual ratings
of cough strength, loudness, and effectiveness. Next to the lines were references for each
perceptual VAS measure. As such, for the perceptual measure of cough strength, a horizontal
tic mark made along the lower end of the line indicated a “weak” cough, a horizontal tic mark
within the mid-range of the line indicated a “moderately strong” cough and a horizontal tic along
the top of the vertical indicated a very strong cough. Precise numerical measurements were
derived by using a ruler to measure the distance from bottom of the vertical line (0) to the
horizontal tic mark provided by the rater. Each perceptual measure was out of a total score of
100.
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Quality Parameter:

Operational Definition:

Huffing:

Blowing or puffing with force during
the cough attempt.

Voicing:

Vocalization during the cough attempt.

Wet / Gurgled:

Cough sounds broken, irregular, or
noisy.

Inspiratory Stridor:

Harsh, grading, or creaking sound
while breath is taken in during first
phase of voluntary cough.

Data Analysis and Statistics
Because of uncertainty about whether the measurement properties of the VAS scale should
be as ordinal or interval data, and uncertainty about the underlying distributions (i.e., normal or
not) of scores given the limited size of the data set, non-parametric Mann Whitney U tests as well
as T tests were used to evaluate the hypotheses that safe and unsafe swallowing groups were
associated with statistically significant different perceptual VAS scores. These tests were
performed for the individual VAS ratings of
Results
A total of 44 individuals (30 male, 14 female) were included in the analysis. See Table 4.2
for description of participants. A blinded rater reviewed the modified barium swallow studies and
identified 26 safe swallowers (PAS < 2) and 18 unsafe swallowers (PAS > 3) within the ALS
participant sample.
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Table 4.2 Participant demographics (N = 44). Sample included 26 participants with unsafe
swallowing as defined by a PAS score < 2, and 18 unsafe swallowers as defined by a PAS score
of > 3.

Variable

Age (years)
ALSFRS-R
Disease Duration
(months)*

Safe
Swallowers

Overall

Unsafe
Swallowers

Mean (SD)

Range

Mean (SD)

Range

Mean (SD)

Range

62 (+/- 10.3)

30 - 83

59 (+/- 11)

30 - 75

66 (+/- 7.6)

57 - 83

33 (+/- 7.9)

16 - 47

34 (+/- 7.4)

16 - 47

30 (+/- 8.3)

16 - 47

21 (+/- 13.4)

8 - 54

21 (+/- 14.8)

1 - 61

21 (+/- 13.8)

1 - 61

*Disease duration as measured from time of symptom onset to clinical study assessment.
Visual Analog Scale
Using a non-parametric statistical approach, a significant group difference was revealed
between mean VAS scores in safe (50.88/100) vs. unsafe (33.56/100) swallow groups for the
perceptual measure of cough effectiveness (U = 148, p = 0.04) while the group difference was just
above our 0.05 significance criteria for the perceptual measure of cough strength (U = 152.5, p =
0.052). Using a parametric approach, a significant difference was revealed between mean VAS
scores in the safe (43.3/100) vs. unsafe (28/100) swallow groups for the perceptual measure of
cough strength (t (42) = 2.08, p < 0.05; (Figure 4.2) and for cough effectiveness (t (42) = 2.10, p
< 0.005).
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Figure 4.2 A bar graph indicating difference in mean perceptual VAS scores of voluntary
cough strength between safe (PAS < 2) vs. unsafe (PAS > 2) swallow groups t(42)=2.08, p <
0.05.

Moderate positive correlations were revealed between perceptual VAS indices and global
disease rating scores. Low perceptual VAS clinical ratings of cough “strength” were associated
with global disease progression (rho = 0.67, p = 0.001). Likewise, low perceptual ratings of cough
“loudness” were associated with global disease progression (rho = 0.68, p = 0.000). Similarly, low
perceptual ratings of cough “effectiveness” were associated with global disease progression (rho
= 0.64, p = 0.000). Additionally, perceptual measures of cough strength and effectiveness with
strongly positively correlated (rho = 0.94, p = 0.00) See Figure 4.3 for scatterplots representing
these correlations.
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Figure 4.3 Scatterplots demonstrating: A) a moderate positive correlation between disease
rating scale score, (the ALS functional rating scale ALSFRS-R) and perceptual VAS ratings of
cough strength; B) a moderate positive correlation between the ALSFRS-R score and loudness
score; C) a moderate positive correlation between the ALSFRS-R score and cough effectiveness
score; and D) a strong correlation between the perceptual rating scores for cough strength and
effectiveness.

Presence/absence of Aberrant Cough Sounds
Voicing was identified as the most aberrant cough sound feature overall as determined by
a frequency count of cough sounds. Huffing was present in a greater number of ALS individuals
who penetrated/aspirated (38.88%) vs. those who did not (3.84%), (χ2 (1) = 8.78, p = 0.003). The
presence of huffing was also associated with swallowing safety status and 10 times more prevalent
in ALS patients with unsafe swallowing (see Table 4.3).
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Table 4.3 Distribution for the presence/absence of perceptual cough features including voicing,
huffing, inspiratory stridor, and wet/gurgled quality. The distribution is represented for the over
group (all 44 participants) and by airway safety group. The presence of “huffing” was revealed
as statistically significant and found in a higher portion on unsafe vs. safe swallowers. Table 4.3
also displays the inter-rater Kappa values as determined between rater 1 and rater 2.

*Participant counted two times in tally for displaying more than one aberrant feature.

Reliability of the VAS for Cough Assessment
Good inter-rater reliability (between rater 1 and rater 2) was revealed for all VAS measures.
ICC values for strength were 0.79 (CI = 95%, 0.615 – 0.885, p = 0.000), ICC values for volume
were 0.79 (CI = 95%, 0.627 – 0.889, p = 0.000), and ICC values for effectiveness were 0.77 (CI
= 95%, 0.592 – 0.879, p = 0.000). Excellent intra-rater reliability was shown for all VAS measures
as assessed by rater 1 at two different time periods (though note that this is based only on 8 sample
points). ICC value for strength was 0.899, volume was 0.945, and effectiveness was 0.906.
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Reliability Binary outcomes
Weak and minimal inter-rater reliability was shown between rater 1 and rater 2 for the
identification (presence or absence) of binary cough quality ratings of huffing, voicing, and
inspiratory stridor, moderate reliability was shown for the detection of the sound wet/gurgles (see
table 4.3). Fair intra-reliability was found between rater 1 assessments of binary measures.
Discussion
This study represents the first attempt to investigate perceptual ratings of cough using a
visual analog scale (VAS) and defined binary ratings of aberrant cough for the assessment of
dysphagia in ALS. Conservatively, the VAS outcome measures were considered ordinal data and
non-parametric statistics were used to assess differences in mean scores between airway safety
groups. There were significant differences in the perceptual measures of cough “effectiveness”
between airway safety groups and this rating was also found to have good inter reliability (between
rater 1 and rater 2 when assessed at different time points).
Visual analog scales are quick methods of obtaining quantifiable information. The
continuous 100 mm line version of the VAS has shown improved sensitivity for measurement of
subjective assessments of pain and mood (Pfennings, Cohen, & Van der Ploeg, 1995). Anchors on
the scale are may represent a point of reference for the rater using the scale and may indicate
opposite descriptors such as “cold and hot”. There are ways to consider improvement of the VAS
scale rating system to evaluate perceptual indices of cough used within this study. The anchor
reference for cough measurement could be changed by using anchors that represent a more
universal point of reference for raters such as color (i.e., bright blue and pale blue). Changing the
reference points to a relatable reference other than extremes of cough may provide more accurate
measurement of what the perceived cough “strength” is.
85

Although the use of VAS scores for the subjective assessment of cough impairment may
only represent incremental improvements in clinical cough measurement and there is debate on
the use of such rating scales in perceptual rating, there remains a dire need to move beyond binary
ratings of clinical cough assessment. As demonstrated in our data, the presence of “huffing” was
present in more patients with unsafe swallowing than safe swallowing, however, this measure was
not shown to be reliable between raters. Clinically, the use of more objective cough measurements
have the potential to: 1) more accurately identify patients with cough impairments who are at high
risk for aspiration; 2) provide a quantifiable, objective measure of cough impairment to identify
pre/post intervention change; and 3) provide a universal system of cough measurement that is
easily accessible to and understood by clinicians.
Limitations and Future Direction
In this investigation, the perceptual judgments of cough strength, loudness, and
effectiveness were assessed via recordings of the cough process. Placement of the recording
devices was not standardized for optimal audiovisual data collection and subsequent analyses.
Future work should include standardization of cough recording during the data collection process;
in addition, both online (during the collection of cough data) and recorded cough sounds should
be assessed. Further work is needed to understand VAS measurements of cough in several patient
populations and to study this measurement in a more controlled manner to limit contextual biases.
Additionally, there remains a need for objective quantification of cough sound patterns to improve
the assessment of patients who are at risk for having undetected dysphagia and/or dystussia.
Conclusions
The goals of this study were to determine if individuals with ALS who were classified by
airway safety groups (safe vs. unsafe swallowing) differed in terms of perceptual measures of
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cough strength, loudness, and effectiveness or in the presence/absence of aberrant cough features.
We hypothesized that measures of cough strength, loudness, and effectiveness would be reduced
in individuals with unsafe swallowing relative to individuals with safe swallowing. Further, we
hypothesized that individuals with unsafe swallowing would demonstrate one or more aberrant
cough features. The results of the study partially supported the hypothesis. Visual analog scale
measurement of cough “effectiveness” was significantly lower in the unsafe swallowing group and
the measurement of “strength” reached near significance and was lower in the unsafe swallowing
group. Additionally, the aberrant cough feature of “huffing” was associated with the unsafe
swallowing group.
This study attempted to identify the perceptual differences within cough features in a way
that could be easily conducted in a clinical setting and quickly interpreted. Although differences
were found for perceptual ratings, the judgments were made retrospectively and further work is
warranted to determine feasibility of use in a clinical setting.
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CHAPTER FIVE
PHYSIOLOGIC ASSESSMENT OF VOLUNTARY COUGH IN ALS
Introduction
Amyotrophic Lateral Sclerosis (ALS) is a progressive and debilitating neurodegenerative
disease resulting in diffuse and progressive muscle wasting and death (Wijesekera, 2009).
Dysphagia, or swallowing impairment, is prevalent in this patient population (Ertekin, 2000).
Presenting symptoms and disease onset are heterogeneous; thus, dysphagia symptoms manifest
differently across patients and can be difficult to assess clinically. Individuals with ALS may
present with bulbar onset of the disease in which case lingual and masticatory deficits are
prominent features of dysphagia. In the spinal onset variant of ALS, limb motor impairment is the
first salient feature identified (Ruoppolo, 2013). Recent evidence indicates that, although patients
with bulbar onset have more prevalent oromotor features; in patients with spinal onset dysarthria
is significantly correlated with presence of dysphagia (Da Costa Franceschini, 2015).
In addition to sensorimotor dysfunction of the swallowing mechanism, ALS
simultaneously results in motor cough deficits, (Plowman et al., 2016) and presumably sensory
cough deficits. Thus, despite onset type, patients are likely to develop pervasive airway protective
dysfunction characterized by both dysphagia and impaired reflexive cough (Ruoppolo, 2013).
There are relationships between cough and swallow at a neural (Gestreau, Grelot, & Bianchi, 2000;
Gestreau, 1996; Oku, Tanaka, & Ezure, 1994) and anatomical/functional level (Pitts, Bolser,
Rosenbek, Troche, & Sapienza, 2008; Plowman, Watts, Robison, Tabor, Dion, Gaziano, Vu, &
Gooch, 2016; Smith Hammond, 2001). Recent work by Plowman and colleagues (2016) has shown
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that impaired voluntary cough function identifies patients with ALS who are at risk for
penetration/aspiration. The authors postulated that there might be clinical utility for the use of
voluntary cough testing to detect presence of dysphagia in this patient population. Although cough
may be a clinically useful tool to determine compromised swallowing function or the ability to
clear aspirant material, cough evaluation methodology and implementation is widely varied
throughout the literature (Watts, Tabor, & Plowman, 2016).
Methodology for common clinical cough testing includes subjective assessments of
strength and/or weakness (as presented in Chapter 3). This is regardless of clinician demographics
such as years of experience, certification status, and/or practice setting. Unfortunately, it has been
shown that subjective assessments of cough are unreliable and are not able to detect swallowing
impairment. For example, McCullough et al. (2005) reported high sensitivities (<79%) but low
specificities (<42%) for detection of aspiration using perceptual ratings. The authors reported that
almost half of the at-risk patients were wrongly categorized based on a “weak” cough rating.
Acoustic measurements of voluntary cough sounds have been investigated in healthy
adults. Olia et al. (2000) studied 234 cough patterns in healthy male and female adults. The authors
subdivided cough patterns into distinct anthropomorphic features consisting of three components
1) explosive phase (phase timing and amplitude, 2) continuous phase (phase timing), and 3) the
variable phase (timing). Authors reported that there were significant differences found between
gender for the length of the expulsive phase, frequency of the first phase, and highest continuous
frequency of the continuous phase. Although there are limitations in acoustic cough analysis, these
studies are necessary to provide objective qualification of a subjective physiologic event. Objective
quantification of cough may help to determine change in airway protection in specific diseases
over time or monitor improvement in airway protection following therapeutic intervention
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(Korpas, 1996).
Therefore, the aim of this study was to determine anthropomorphic characteristics of
voluntary cough acoustic signals in individuals with ALS and healthy controls. Given differences
in anthropomorphic features of cough previously found in participants with and without lung
disease, it is hypothesized that there will be anthropomorphic differences between healthy controls
and patients with ALS and between patients with ALS who are safe swallowers and those who are
not safe swallowers.
Methods
Participants
Participants included 10 patients diagnosed with ALS according the El Escorial Criteria
(Brooks et al., 2000); 5 males and 5 females with bulbar, spinal, and mixed disease onsets, and 10
healthy aged-matched controls; 5 males and 5 females with no known history of pulmonary
disease. ALS patients were recruited from the Morsani Medical Center’s ALS neurology clinic,
and the Center for Swallowing Disorders. This study received approval by the University of South
Florida Institutional Review Board (#00023151) (see Appendix D) In addition to the diagnoses
above, specific inclusion criteria included: 1) cognition within normal limits as determined by >
24 points on the Mini Mental Status Exam (Reisberg, 1982). Specific exclusion criteria include:
1) presence of tracheotomy or mechanical ventilation; 2) presence of diaphragmatic pacer; 3)
diagnosis of significant concurrent respiratory disease (e.g. COPD); or 4) allergies to barium.
Testing Protocol
Once enrolled, participants were assigned a study number and underwent all testing
procedures on the same day. Data collection was counterbalanced in order to account for fatigue
in this patient population. Assessments included: 1) swallowing evaluation using
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videofluoroscopy; 2) physiologic cough spirometry testing coupled with acoustic recording; 3)
voluntary peak expiratory flow rate cough testing; 4) spirometry testing; and 5) completion of
disease-specific rating scales including the ALS functional rating scale revised (ALSFRS-R)
(Cedarbaum, et al., 1999).
Swallowing
Swallowing was assessed using the modified barium swallow study (MBSS). The MBSS
is the gold standard evaluation for swallowing function. Participants were seated in an upright
position. A Phillips BV Endura fluoroscopic C-arm unit (GE OEC 8800 Digital Mobile C-Arm
system type 718074) was used to collect radiographic images of the swallow (30 frames/second);
images were collected in both a lateral and anterior-posterior viewing plane. A Kay Pentax
Swallowing Signals Lab unit (Kay Pentax, Lincoln Park, NJ) digitally recorded the fluoroscopic
images that were stored for subsequent analysis. The standardized protocol consistent of the
following bolus challenges: 1) 1-cc, 5-cc, 10-cc and cup sips of ultra-thin liquid contrast, 2) 5-cc
of barium paste, and 3) ¼ of graham cracker coated with 5 cc barium paste in the lateral view; and
4) cup sips of ultra-thin barium liquid, 5) ¼ of graham cracker coated with 5 cc barium paste, and
6) 13-mm barium tablet in the anterior/posterior view. To ensure patient safety, the sequence of
bolus presentations may have been altered. The MBS study was discontinued if the patient silently
aspirated and could not tolerate further swallow testing procedures.
Acquisition of Cough Airflow and Acoustic Waveforms
Cough airflow during voluntary cough was assessed for each patient using spirometry.
Patients were asked to “cough as if something were stuck in your throat.” Prior to airflow data
collection, the airflow signal was calibrated using a 3-liter syringe. The patient was placed in a
seated position; a spirometer filter (MQ 304 Spirometer Filter, Vacumed; Ventura, CA) was
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coupled to an oral pneumotachograph (MLT 1000, ADInstruments, Inc; Colorado Springs, CO).
The airflow signal was measured via a spirometer (ADInstruments, Inc, Colorado Springs, CO),
which was attached to data acquisition hardware (PowerLab System 16/35, ADInstruments, Inc).
Acoustic cough recordings were collected in conjunction with airflow measures and
independent of airflow measures (Figure 5.1). An Audio-technica microphone (ATM73a) with the
mouthpiece placed at a standardized distance from the patient’s oral cavity. Prior to collection of
acoustic cough data, the acoustic signal was calibrated using a 90 dB pure tone. The microphone
was routed to a preamplifier unit and the signal split into two A/D channels. Via software control,
the sensitivity of each channel was set to allow simultaneous low and high-sensitivity recordings.
This allowed for very high cough sound pressure levels to be recorded without clipping on the
low-sensitivity channel and very low sound pressure levels to be recorded with an adequate signalto-noise ratio. Audiovisual recording of the cough assessment was obtained using a Sony HD
HandyCam video recorder positioned directly in line with the patient at a three-foot distance.
Data Analysis and Statistics
Cough Airflow
Offline analysis of the airflow and acoustic waveforms were completed using separate
software utilities consisting of a series of MATLAB scripts. Each of the MATLAB utilities
included several automatic assessment features to reduce measurement error (Appendix E).
For the airflow waveform, physiologic aspects of the cough airflow signal were measured as in
previous investigations of voluntary cough production, (Smith Hammond C.A., 2001). As
previously described in publications of cough airflow analysis, the following measures of cough
airflow were derived with MATLAB software scripts: 1) inspiratory phase duration: this is defined
in the literature as the time from the start of the inspiratory event (airflow crossing 0 L/s) to the
92

beginning the compression phase of cough (airflow reaches 0 L/s and remains relatively stable);
2) inspiratory peak flow: this is determined as the lowest peak measurement during the inspiration
(-L/s); 3) compression phase duration: commonly defined within the literature as time total time
of glottis closure measured from the end of the inspiration to the start of the expiratory phase; 4)
expiratory rise time: this time measurement is referred to as the time it takes from the opening of
the glottis to reach peak expiratory flow. It is measured from the start of the expiratory phase to
the time the peak expiratory flow occurs; 5) expiratory peak airflow: this is referred to as the
highest peak point during a cough expiration. It is measured by identifying the highest peak in an
expiration (L/s); and 6) cough volume acceleration: this measurement is a calculation of expiratory
peak flow/expiratory rise time often described within the literature as the effectiveness of the
cough. These samples were analyzed separately from the acoustic analysis and were derived at
separate intervals during the cough testing procedure.
Cough Acoustics
Analysis of acoustic cough waveforms were processed and measured using the LabChart
(version

7)

software

and

subsequently

exported

to

MATLAB

(Mathworks,

Inc.).

Anthropomorphic features of cough sound included the following measures: (see figure 5.2). 1)
expulsive cough phase time: onset time of the cough signal to the time of the first peak frequency;
2) continuous cough phase time: time from the first peak frequency to the time of the second peak
frequency; 3) variable cough phase time: time of the second peak frequency to the end of the
acoustic cough signal; 4) total length of acoustic cough signal: time from the onset of the acoustic
cough signal to the end of the acoustic cough signal; and 5) augmenting and decrementing cough
pattern: acoustic cough recording in microvolts (mV) was analyzed for the cough signal pattern
(see Figure 5.3).
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Figure 5.1 Image depicts a sample data collection page rendered using LabChart version7. Time
is along the x-axis. There are 4 panels displayed along the y-axis. The first panel represents the
raw cough waveform, second panel represents the filtered cough waveform, third panel is a high
sensitivity data capture of acoustic recording and the fourth panel is a low sensitivity data capture
of acoustic signal. Acoustic data were collected in two ways, simultaneously with airflow
(pictured) and independently (not pictured) without airflow. Acoustic recordings without airflow
were used for analysis.
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Figure 5.2 Anthropomorphic features of acoustic cough signals were tagged and recorded. Time
and peak amplitude were analyzed to derive final measures: A) onset time of the cough signal
to the time of the first peak frequency B) time from the first peak frequency to the time of the
second peak frequency, and C) time of the second peak frequency to the end of the acoustic
cough signal.
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Figure 5.3 Cough waveform variations were classified for single acoustic cough signals; they
were analyzed from the same recording channel for each subject according to the following
definitions: A) fast augmenting signal and fast decrementing signal; B) slow augmenting and
slow decrementing signal; C) fast augmenting and slow decrementing signal; and D) slow
augmenting and fast decrementing acoustic signal.

Handheld Peak Flow Meter Testing
Voluntary peak cough airflow was measured for each patient using a portable, hand-held
flow meter. The patient remained in a seated position. A Mini Wright Peak Flow Meter (KW Med,
Inc., Antioch, IL) was placed in the patient’s mouth. The clinician helped to create a tight lip seal
around mouthpiece. If needed, the nose was occluded with nose clips for the cough task. The
patient was asked to cough “as if something were stuck in their throat.” Standard-range (60 to 850
liters per minute) and low-range (30 to 400 liters per minute) peak flow meters were available for
testing depending on the patients’ typical airflow. Each patient performed three trials of the peak
cough flow test; an average of the three trials was used for subsequent analysis.
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Respiratory function
Forced vital capacity (FVC) was assessed with a Micro 1 Handheld Spirometer
(CareFusion, Vyaire Medical, Mettawa, IL). The patient was instructed to sit fully upright and
performed a maximal inhalation and exhalation effort with cueing from the experimenter.
Statistical Analysis
Descriptive statistics including mean, standard deviation, and range were used to describe
demographic characteristics of the sample. Given the largely heterogeneous presentation of the
sample population, normal distribution was not assumed. Therefore, the non-parametric Mann
Whitney U Test was used to compare sample means between cough airflow measures in safe (PAS
< 2) and unsafe swallowing groups (PAS > 3); and anthropomorphic acoustic cough measures
between healthy controls and patients with ALS and across airway safety groups in ALS.
Spearman’s Rho Correlation analysis with alpha set at 0.05 was utilized be used to determine
associations between continuous spirometry data and voluntary cough airflow and acoustic
measures.
Results
Patient Demographics
Ten patients with ALS underwent evaluation. Mean age of the sample was 63 years (range
39-73 years), and 50% of the sample was female. All subjects scored > 26 on the MMSE and were
deemed appropriate to participate in the cough and swallow evaluation protocols. Table 5.1
summarizes the demographic and disease data for each subject. Of the ten ALS patients evaluated,
5 patients were judged to have unsafe swallowing (PAS score > 3) as evaluated during any swallow
task completed during the swallow study protocol (see Table 5.1, second column). Peak cough
flow testing and respiratory function information for each patient can be found in table 5.2. In
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addition, 10 healthy control subjects underwent acoustic cough evaluation. Mean age of the control
sample was 59.2 years (range 42 to 75 years), and 50% of the sample was female.
Table 5.1 ALS participant demographics including global disease rating scale with subscale
bulbar and respiratory domain data. *Disease duration is reported as time (in months) from
reported symptom onset to study assessment date.

Participant
ID

Gender

PAS
Score

ALSFRS-R
Score

ALSFRS-R
Bulbar

ALSFRS-R
Respiratory

Disease
Onset

Disease
Duration
(mo.)*

1
2
3
4
5
6
7
8
9
10

M
F
M
F
M
M
F
M
M
F

7
8
2
3
7
2
2
1
7
2

26
29
24
32
24
30
22
20
39
26

3
0
11
9
7
12
7
10
8
9

5
9
6
10
7
7
6
9
9
8

Bulbar
Bulbar
Spinal
Bulbar
Bulbar
Spinal
Bulbar
Spinal
Bulbar
Spinal

37
22
62
34
38
24
26
91
36
17

Table 5.2 ALS participants respiratory function including forced expiratory volume (FEV1),
forced vital capacity (FVC), FEV1/FVC, and peak expiratory flow as measured by a hand held
analog peak flow meter. *Average peak flow as calculated from three voluntary cough trials.

Participant
ID

PAS
Score

1
2
3
4
5
6
7
8
9
10

7
8
2
3
7
2
2
1
7
2

Gender FEV1

M
F
M
F
M
M
F
M
M
F

26
39
53
96
70
41
68
32
102
70

Predicted (%)
FVC FEV1/FVC

54
57
43
106
65
38
69
29
100
68

98

48
76
126
99
110
109
109
115
107
108

PEF Average*
(hand held
meter)
L/m
213
200
143
200
283
193
146
163
146
233

Voluntary Cough Airflow in Patients with ALS
The modified barium swallow study identified 5 safe swallowers (PAS < 2) and 5 unsafe
swallowers (PAS > 2) within the ALS participant sample.
Cough Airflow Data
Based on cough airflow data, no significant differences were revealed between airway
safety groups for average cough airflow characteristics. There was a significant difference between
compression phase duration (CPD) for epoch 1, cough 1 between airway safety groups (U = 8, p
= 0.032). The unsafe swallowing group exhibited a slightly longer compression phase duration
than the unsafe swallowing group. The air-flow characteristics inspiratory phase duration,
expiratory rise time, peak expiratory flow, and cough volume acceleration were not significantly
different between the safe and unsafe groups.
Anthropomorphic Features of Cough
Anthropomorphic acoustic cough features were analyzed based on acoustic cough
waveforms collected without coupled airflow data. Healthy controls (n = 10) and ALS participants
(n = 10) were compared. Significant differences were detected between healthy controls and
patients with ALS for continuous cough phase time (U = 69, p = 0.02). In healthy participants, the
mean continuous phase length was longer than individuals with ALS (12.4 ms vs. 8.6 ms). No
other anthropomorphic features such as expulsive phase time, variable phase time, or expulsive
phase peak amplitude were significantly different between healthy controls and ALS participants.
Additional analysis was performed to determine if there were differences in
anthropomorphic features between safe and unsafe swallowers. There were significant differences
identified for expulsion phase time (U = 2, p = 0.03). The unsafe swallowing group exhibited
longer expulsive phase time (M = 3.4 seconds +/- 4.7) than the unsafe swallowers (M = 7.60
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seconds, +/- 4.7). Although the measure of total acoustic cough length did not meet the 0.05
significance criteria, total cough length was found to be longer in unsafe swallowers (M = 7.4 ms)
compared to safe swallowers (M = 3.6 ms) (U = 3, p = 0.056). No differences were determined for
group means for the variable or continuous phases or peak expulsive amplitude.
Further analysis was performed between ALS participants; in this analysis, groups were
stratified based on aspiration status. PAS > 6 versus safe swallowers with penetrators were
compared. In participants who aspirated, there was a significant difference in total cough duration,
(U = 0, p = 0.01). Total cough length was longer in participants who aspirated (M = 0.99 ms)
versus those who did not (M = 0.36 ms). Significant difference between mean expulsive phase rise
time was identified between groups (U = 0, p = 0.01. The expulsive phase time was longer in
individuals who aspirated (M = 0.3 ms) verses those who did not (M = 0.02 ms). There was also
a significant difference for the measure, variable phase time between groups (U = 1, p = 0.01). The
mean variable phase time was longer in the aspiration group (M = 0.42 ms) versus the nonaspiration group (M = 0.18). Lastly, peak expulsive phase amplitude was lower in participants who
aspirated versus those who did not (U = 1, p = 0.01). Mean amplitude for the aspiration group =
117.7 mV and the non-aspiration group mean amplitude = 318.5 mV.
Augmenting and decrementing cough pattern
Based on the cough acoustic waveform signal patterns collected independently from
airflow signals results showed that all healthy controls (10/10 or 100%) presented with fast onset
cough pattern. Of the ten ALS participants, seven participants displayed a fast cough onset, and of
those 7 individuals, all were safe swallowers who did not aspirate. No healthy controls exhibited
a slow augmenting acoustic cough pattern whereas 40% (4/10) of ALS participants had a slow
augmenting cough pattern. Four of ten healthy individuals presented with a slow decrementing
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cough pattern and 7 of 10 ALS participants presented with a slow decrementing cough pattern.

Figure 5.4 Depicted in three panels, A., B., and C. are airflow, acoustic, and spectral
representations of cough in safe (PAS < 2) and unsafe (PAS > 3) swallowers. Figure 5.4 panel
B. depicts a fast augmenting and fast decrementing cough pattern found in a safe swallowers
and a slow augmenting slow decrementing cough pattern as found and unsafe swallower.

Discussion
This is the first study to evaluate anthropomorphic features of cough in healthy controls
and ALS participants. The results of this study showed that there are salient features of acoustic
voluntary cough signals that are different when comparing aspirators to non-aspirators. However,
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no significant differences were found between anthropomorphic features of cough in healthy
controls and ALS participants, or voluntary airflow measures between safe and unsafe ALS
participants. This data does not confirm what has been previously published (Plowman, Watts,
Robison, Tabor, Dion, Gaziano, Vu, & Gooch, 2016), and may be due to our small sample size.
The present study included a mixed sample of both spinal and bulbar onset ALS in the
advanced stages of the disease, and thus, both bulbar and spinal features were present in all
participants. Not surprising, the unsafe group had patients of both bulbar and spinal onset,
reflecting a global degeneration of cardinal motor symptoms and corticobulbar degeneration. It is
likely that insidious motor dysfunction across the neural axis contributed to these findings as
lesions anywhere along the neuraxis may impact cough motor and subsequently acoustic function.
Physiological impairment leading to dystussia may have origins in airway afferent
impairment, respiratory muscle weakness, or a combination of both. In terms of motor impairment,
chest wall rigidity in patients with PD decreases their ability to inflate the lungs (Pitts, 2008). The
work of Ebihara and colleagues (2003) indicated that involvement of motor and sensory
impairment might depend on the stage of PD progression. In contrast, the ALS patient population
presents in a heterogeneous manner and it is difficult to evaluate and benchmark impairment
especially using clinical indices such as perception via rating scales and even with more objective
measures. Results suggest that the cough and swallow relationship in ALS may be a much less
linear relationship between the physiologic parameters as has previously postulated. These results
may also be reflective of a small sample size.
Voluntary cough sound patterns have been shown to detect abnormality in pulmonary lung
function in human models (Abaza, 2009). Abaza and colleagues (2009) investigated simultaneous
voluntary cough airflow and sound pressure waves (time in seconds over amplitude) using a high
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fidelity recording system composed of a mouthpiece attached to a metal tube with a microphone.
The participants (52 health adults and 60 individuals with lung disorders, both male and female)
watched a short video on how to perform a voluntary cough test. They then were instructed to,
“keep their glottis open” as they, “coughed vigorously” (Abaza, p. 2) in order to prevent sound
due to glottal closure. Authors used novel methodology to classify cough sound and airflow
patterns. They reported that this methodology yielded a 94% rate of identifying abnormal lung
function in female subjects and 97% rate for identifying abnormal lung function in male subjects.
As professionals, speech language pathologists have evaluated voice quality in both
subjective (often with visual analog scales) and objective (vocal acoustic signal) manners as well
as with models that invoke auditory-processing front-ends to capture the non-linear transformation
of sound into perceptual constructs (Eddins, 2016; Shrivastav, 2011, 2003). Specifically, there
have been robust studies of acoustic parameters of subjective quality in voice. However, subjective
ratings of breathy voice quality have been found unreliable (Kreiman et al., 1993, Dejonckere,
Obbens, De Moor, Wieneke, 1993) in some studies while very reliable in other studies (Bassich &
Ludlow, 1986). Thus acoustic measures are often used provide objective quantification of voice
quality (Bhuta, 2004). However, there is a clear disconnect between acoustic and perceptual
indices of voice due to the non-linear nature of the perception of sound. Thus, it is not surprising
that perceptual and acoustic correlates of voice quality are often in poor agreement. Cough creates
a distinct sound pattern during the transition from a compression phase, or closure of the glottis,
to expiration is completed (Korpas, 1996). Given the presence of a perceptual sound pattern, it is
assumed that there are also unique acoustic characteristics that determine and aberrant cough.
Additionally, Laciuga et al. (2016) identified that physiologic characteristics are associated with
certain perceptual aspects of cough. Nevertheless, assessment of perceptual strength and
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effectiveness of cough was less consistent using ratings such as scales and the authors suggested
that there should be a more uniform way of judging the perceptual attributes of cough (Laciuga,
Brandimore, Troche, & Hegland, 2016).
Our study revealed swallowing safety group differences for cough airflow measurements
but did reveal group-dependent differences in measures within the acoustic cough signal.
Additionally, when comparing aspirators to non-aspirators, there were multiple differences in
anthropomorphic cough features. This disparity in results may represent that laryngeal structures
participating the production of cough and resulting the cough sound pattern are a salient feature of
cough impairment. The structure of the laryngeal and pharynx responsible for the sound of a cough
may be an important feature of aberrant cough to investigate beyond cough airflow data.
Limitations and Future Directions
One limitation of the current study is that, the data were recorded and analyzed by the same
researcher. This presents a potential confound as the results may be analyzed and interpreted with
bias. A second limitation is that the study represented a small sample of patients. Finally, the
analyses were somewhat simplistic. Future work should include a more sophisticated set of
analyses, blind analyses, and a larger group of samples
Conclusions
The aim of this study was to determine anthropomorphic characteristics of voluntary
cough acoustic signals in individuals with ALS and healthy controls. We hypothesized that there
would be anthropomorphic differences between healthy controls and patients with ALS and
between patients with ALS who are safe swallowers and those who are not safe swallowers. Our
results did partially supported hypothesis. Significant differences in the continuous cough phase
were identified; healthy participants demonstrated longer continuous cough phase times than
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individuals with ALS. This may reflect ability to reach peak flows.
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CHAPTER SIX
CONCLUSIONS AND FUTURE DIRECTIONS

Results from the studies reported in this dissertation represent several additions to the current
literature on cough and swallowing. There are well-established relationships between cough and
swallowing in clinical populations. The relevance of such work is paramount for professionals
who serve populations with impaired swallow ability as traditional methods of clinical swallowing
assessment often fail to identify those with impaired swallowing who silently aspirate (i.e., no
reflexive cough). In addition, dystussia promotes poor airway protection and must be a target of
evaluation and intervention. Review of current literature indicates that there are several novel
testing options for cough evaluation within both the voluntary and reflexive methodologies.
However, these are not readily available for clinical use and have varied measures of sensitivity
and specificity, which are not suitable for clinical use (Watts, Tabor & Plowman, 2016).
Additionally, current binary subjective measures (i.e., strong/weak) used during clinical swallow
assessments fail to provide quantitative data or describe deviant auditory features of cough.
Cough evaluation within the clinical setting is gaining attention. The survey study
completed by 605 participants’ revealed that a majority of individuals across practice settings,
levels of experience, and certification are assessing coughing in their clinical practice. The measure
of “strength” is used most constantly. However, strength is a continuum of performance and not a
binary outcome. With a growing body of basic and clinical literature demonstrating strong
relationships between swallowing and airway protective behaviors; there is an urgent need for
106

standardization of cough assessment protocols and terminology.
Although there are studies that focus on the relationship between cough and swallow, there
is a paucity of data on clinician reliability of assessing cough function, or deviant audible features
of dystussia which may inform clinicians of decreased airway protection. The third study
investigated perceptual ratings of cough using a visual analog scale (VAS) and defined binary
ratings of aberrant cough. The study showed promising results for revealing differences between
airway safety groups for perceptual measures of effectiveness and binary measures of “huffing”.
However, in line with literature concerning the use of VAS scales in perceptual analysis, the
measures were largely unreliable between different raters.
The fourth study aimed to investigate a novel method of cough evaluation for the purpose
of identifying safe versus unsafe swallowers and differentiating cough patterns between healthy
controls and ALS participants. Differences in anthropomorphic features of cough based on
(airflow, acoustics, both?) between aspirators and non-aspirators indicate that there are salient
features between airway safety groups that differ and may help identify those at risk for aspiration.
Unfortunately, the evaluation method failed to differentiate healthy controls versus ALS
participants suggesting this methodology may not yield favorable sensitivity and specificity
results.
The systematic studies presented inherent limitations such as having non-standardized
acoustic recordings of cough for VAS analysis, non-standardization of blinding methods for
anthropomorphic analysis, and small number of participants. However, given several significant
findings across the body of work, further investigation is required in order to continue to identify
salient features of aberrant cough that differentiate patients who are at risk for poor airway
protection and potentially help decrease morbidity and mortality due to pulmonary injury.
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APPENDIX B:
SURVEY IRB

June 5, 2015
Stephanie Watts (Randall)
Communication Sciences and Disorders
Tampa, FL 33604

RE:
IRB#:
Title:

Exempt Certification
Pro00017474
Survey of Clinical Swallow Evaluation
Practices

Dear Ms. Watts (Randall):
On 6/5/2015, the Institutional Review Board (IRB) determined that your research meets criteria
for exemption from the federal regulations as outlined by 45CFR46.101(b):
(2) Research involving the use of educational tests (cognitive, diagnostic, aptitude,
achievement), survey procedures, interview procedures or observation of public behavior,
unless:
(i) Information obtained is recorded in such a manner that human subjects can be identified,
directly or through identifiers linked to the subjects; and (ii) any disclosure of the human
subjects' responses outside the research could reasonably place the subjects at risk of
criminal or civil liability or be damaging to the subjects' financial standing, employability, or
reputation.
Approved Items:
Protocol_5.22.15
Informed Consent
As the principal investigator for this study, it is your responsibility to ensure that this research
is conducted as outlined in your application and consistent with the ethical principles outlined
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in the Belmont Report and with USF IRB policies and procedures.
Please note, as per USF IRB Policy 303, "Once the Exempt determination is made, the
application is closed in eIRB. Any proposed or anticipated changes to the study design that
was previously declared exempt from IRB review must be submitted to the IRB as a new
study prior to initiation of the change."
If alterations are made to the study design that change the review category from Exempt (i.e.,
adding a focus group, access to identifying information, adding a vulnerable population, or an
intervention), these changes require a new application. However, administrative changes,
including changes in research personnel, do not warrant an amendment or new application.
Given the determination of exemption, this application is being closed in ARC. This does not
limit your ability to conduct your research project. Again, your research may continue as
planned; only a change in the study design that would affect the exempt determination requires
a new submission to the IRB.
We appreciate your dedication to the ethical conduct of human subject research at the
University of South Florida and your continued commitment to human research protections. If
you have any questions regarding this matter, please call 813-974-5638.

Sincerely,

Kristen Salomon, Ph.D.,
Vice Chairperson USF Institutional
Review Board
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APPENDIX C:
SURVEY OF CLINICAL SWALLOW EVALUATION PRACTICES

*Mandatory questions are denoted with an asterisk
*1) Are you a Speech Language Pathologist (SLP) or SLP student?
1. Yes
2. No

2) What is your professional title?
1. Medical Doctor (MD)
2. Registered Nurse (RN)
3. Licensed Practical Nurse (LPN)
4. Other: Please type in title:

3) What is your speech language certification? Please select all that apply.
1. Ph.D.
2. BRS-S
3. CCC-SLP
4. CF-SLP
5. SLPA
6. Student
*4) Years of experience in medical SLP practice.
1. <1 year
2. 1-2 years
3. 3-5 years
4. 6-10 years
5. 11-20 years
6. 20 + years
*5) Country where you practice
1. United States
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2. Canada
3. None of the above

*6) State where you practice
1-50. Select drop down of U.S. states
*7) Which type of facility do you work in? Pick all that apply.
1. Skilled nursing facility (SNF)
2. Hospital
3. Private practice
4. Voice center
5. Swallow center
6. Voice and swallow center
7. University medical clinic
8. SLP graduate training clinic
9. Outpatient rehabilitation
10. Other
*8) Please select all that apply in regards to your main caseload.
1. Outpatient rehabilitation
2. Inpatient rehabilitation
3. Acute
4. Sub-acute
5. ICU
6. SICU
7. Other
*9) Do you conduct clinical (bedside) swallow examinations?
1. Yes
2. No
*10) What populations do you assess with a clinical swallow evaluation? Select all that
apply.
1. Neurogenic
2. Head and Neck
3. Trauma
4. Cardiac Care
5. Long-term care
6. Post surgical
7. Other
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11) Why do you not perform clinical swallow evaluations? Select all that apply.
1. I am not trained in conducting clinical swallow evaluations
2. I only perform instrumental examinations
3. Clinical swallow does not provide adequate diagnostic information
4. In none of the above, please provide other reason(s)
*12) Do you perform an oral mechanism examination during your clinical swallow
evaluation?
1. Yes
2. No
*13) Do you assess voluntary cough (e.g., ask the patient to preform a cough)?
1. Yes
2. No
*14. What aspects of voluntary cough do you listen for to indicate abnormality (e.g.,
strength)?
1. Open typed response
*15). Please list all of the components of you clinical swallowing evaluation.
1. Open typed response
*16) Please select the validated swallow protocols you are familiar with (you may select
more than one).
1. Yale 3 oz. water swallow test
2. The Toronto Bedside Swallow Screening Test (TOR-BSST)
3. Gugging Swallowing Screen
4. Modified Mann Assessment of Swallowing Ability (MMASA)
5. Other
*17) Of the previous validated swallow protocols you selected, do you implement and of
these in clinical practice?
1. Yes
2. No
18) If you do not implement validated clinical swallow protocols, please briefly indicate
why. 1. Open typed response
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APPENDIX D:
PERCEPTUAL AND PHYSIOLOGIC COUGH ASSESSMENT IRB

10/5/2015
Stephanie Watts (Randall)
Communication Sciences and Disorders
1017 E Crenshaw Street
Tampa, FL 33604

RE: Full Board Approval for Initial Review
IRB#: Pro00023151
Title: Perceptual and Physiologic Analysis of Dystussia for the Assessment of Dysphagia
STUDY APPROVAL PERIOD: 10/5/2015 TO 10/5/2016
Dear Ms. Watts:
On 10/5/2015, the Institutional Review Board (IRB) reviewed and APPROVED the above
application and all documents contained within, including those outlined below.
Approved Item(s):
Protocol
Document(s):
Protocol V2 CLEAN
CONSENT/ASSENT DOCUMENT(S)*:
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Dystussia ICF V3 CLEAN.pdf

*Please use only the official IRB stamped informed consent/assent document(s) found under
the "Attachments" tab. Please note, these consent/assent document(s) are only valid during the
approval period indicated at the top of the form(s).
As the principal investigator of this study, it is your responsibility to conduct this study in
accordance with IRB policies and procedures and as approved by the IRB. Any changes to the
approved research must be submitted to the IRB for review and approval via an amendment.
Additionally, all unanticipated problems must be reported to the USF IRB within five (5)
calendar days.
We appreciate your dedication to the ethical conduct of human subject research at the
University of South Florida and your continued commitment to human research protections.
If you have any questions regarding this matter, please call 813-974-5638.

Sincerely,

E. Verena Jorgensen, M.D., Chairperson
USF Institutional Review Board
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APPENDIX E:
MATLAB CODING

%run data analysis
clear all; clc; close all;
rootdir = pwd;
addpath(genpath(rootdir));
[filename,path] = uigetfile();
data.fullname = fullfile(path,filename);
data.filepath = path;
data.filename = filename;
[alldata,time] = importData(data.fullname);
chansegexp = inputdlg({'Enter Channel Number','Enter Segment Number','Enter Master File for Export'},'Select
Data',1,{'2','4','masterfile.xlsx'});
chan = str2double(chansegexp{1});
seg = str2double(chansegexp{2});
data.exportFN = chansegexp{3};
data.x = time{chan,seg}';
data.y = alldata{chan,seg};
data.finish = 0;
%begin analysis of this file
idx = 1; %keep track all files/segments
%get data points
while ~data.finish
[handles.brushPage,data] = brushPage(data);
%set(handles.brushPage,'Visible','off');
[handles.analysisPage,data] = analysisPage(data);
% set(handles.analysisPage,'Visible','off');
allData{idx} = data;
idx = idx + 1;
end

%calculate all derived measures
for ii = 1:length(allData)
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%IPD (B-A) in time
allData{ii}.IPD = allData{ii}.B(1)-allData{ii}.A(1);
%IPFF (E)
allData{ii}.IPPF = allData{ii}.E(2);
%CPD (C-B) in time
allData{ii}.CPD = allData{ii}.C(1)-allData{ii}.B(1);
%EPRT (D-C) in time
allData{ii}.EPRT = allData{ii}.D(1)-allData{ii}.C(1);
%EP (D - C) in amplitude
allData{ii}.EP = allData{ii}.D(2) - allData{ii}.C(2);
%CVA (D/(D-C)) in ampliude/time
allData{ii}.CVA = allData{ii}.EP/allData{ii}.EPRT;
end

[pth,name,ext] = fileparts(data.filename);
datafile = fullfile(rootdir,'export',[name,'_export',ext]);
%save to files
save(datafile,'allData'); %mat file
exportData(allData); %xlsx file
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